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Abnormal Smooth Muscle Contraction Alters Gut Motility and Propagates
Epithelial invasion in the Larval Zebrafish Intestine
Abstract
Coordinated smooth muscle contraction is critical for force production and proper functioning of
numerous organ systems. Activation at the myosin motor domain via phosphorylated myosin light chain
(phospho-MLC) remains the primary signal to initiate contraction, but it is now appreciated that there are
additional force modulators also present in smooth muscle. One particularly well studied modulatory
protein is Caldesmon (CaD), which has been implicated in controlling contractile force in vascular smooth
muscle, however little is known of CaD's physiological role in vivo. Studies in vitro have shown that CaD
inhibits actomyosin interactions and that this effect is reversed after phosphorylation, allowing for greater
force propagation. Since a number of gastrointestinal (GI) tract and vascular disorders are known to be a
result of aberrant force production, closely monitoring CaD's functional properties may provide insight
into common contractile defects. We took advantage of the transparent nature of the intestine in larval
zebrafish to study CaD's effect on smooth muscle contraction in a vertebrate model. We initiated these
studies by examining propulsive peristalsis in the larval intestine after knockdown of endogenous smooth
muscle CaD protein. We next measured the role of CaD in the absence of phospho-MLC to better
understand its function in disease states where myosin activation is perturbed. Using extensive live
imaging analysis, we show that disrupting CaD function within intestinal smooth muscle can significantly
increase GI motility, with and without phospho-MLC, highlighting CaD's ability to independently modulate
contractile force. In addition, previous work on a mutant, meltdown (mlt), in our lab has uncovered a
smooth muscle myosin (myh11) mutation leading to increased contractile force and premature CaD
phosphorylation. Interestingly, in the mlt mutant intestinal epithelial invasion was observed pointing to the
unique role for force propagation in initiating cell invasion. We show that CaD is necessary for mlt
epithelial invasion to occur, as knockdown of CaD causes the invasive phenotype in heterozygous mlt,
which otherwise appear wild type. To gain a better understanding of the crosstalk between muscle
contraction and epithelial invasion, we performed a genetic screen for modifier mutants of the mlt
phenotype. From the screen, we discovered two enhancer mutants of mlt that contained missense
mutations in unique protein domains of MYH11 that alter the contractile function of smooth muscle.
These mutations (S237Y and L1287M) occur in both the motor domain and helical tail domain of the
protein, suggesting that alterations in distinct regions of myosin can result in abnormal contraction and
potentially lead to invasion in underlying cells. Since a number of myosin mutations have been implicated
in vascular disease and colon cancer, these studies provide insight into the diversity and mechanistic
consequences of mutated myosin in altering smooth muscle contraction and epithelial cell invasion.
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ABSTRACT
ABNORMAL SMOOTH MUSCLE CONTRACTION ALTERS GUT
MOTILITY AND PROPAGATES EPITHELIAL INVASION IN THE
LARVAL ZEBRAFISH INTESTINE
Joshua M. Abrams
Michael A. Pack
Coordinated smooth muscle contraction is critical for force production and proper functioning of numerous
organ systems. Activation at the myosin motor domain via phosphorylated myosin light chain (phosphoMLC) remains the primary signal to initiate contraction, but it is now appreciated that there are additional
force modulators also present in smooth muscle. One particularly well studied modulatory protein is
Caldesmon (CaD), which has been implicated in controlling contractile force in vascular smooth muscle,
however little is known of CaD’s physiological role in vivo. Studies in vitro have shown that CaD inhibits
actomyosin interactions and that this effect is reversed after phosphorylation, allowing for greater force
propagation. Since a number of gastrointestinal (GI) tract and vascular disorders are known to be a result
of aberrant force production, closely monitoring CaD’s functional properties may provide insight into
common contractile defects. We took advantage of the transparent nature of the intestine in larval zebrafish
to study CaD’s effect on smooth muscle contraction in a vertebrate model. We initiated these studies by
examining propulsive peristalsis in the larval intestine after knockdown of endogenous smooth muscle CaD
protein. We next measured the role of CaD in the absence of phospho-MLC to better understand its
function in disease states where myosin activation is perturbed. Using extensive live imaging analysis, we
show that disrupting CaD function within intestinal smooth muscle can significantly increase GI motility,
with and without phospho-MLC, highlighting CaD’s ability to independently modulate contractile force. In
addition, previous work on a mutant, meltdown (mlt), in our lab has uncovered a smooth muscle myosin
(myh11) mutation leading to increased contractile force and premature CaD phosphorylation. Interestingly,
in the mlt mutant intestinal epithelial invasion was observed pointing to the unique role for force
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propagation in initiating cell invasion. We show that CaD is necessary for mlt epithelial invasion to occur,
as knockdown of CaD causes the invasive phenotype in heterozygous mlt, which otherwise appear wild
type. To gain a better understanding of the crosstalk between muscle contraction and epithelial invasion,
we performed a genetic screen for modifier mutants of the mlt phenotype. From the screen, we discovered
two enhancer mutants of mlt that contained missense mutations in unique protein domains of MYH11 that
alter the contractile function of smooth muscle. These mutations (S237Y and L1287M) occur in both the
motor domain and helical tail domain of the protein, suggesting that alterations in distinct regions of
myosin can result in abnormal contraction and potentially lead to invasion in underlying cells. Since a
number of myosin mutations have been implicated in vascular disease and colon cancer, these studies
provide insight into the diversity and mechanistic consequences of mutated myosin in altering smooth
muscle contraction and epithelial cell invasion.
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Chapter 1: Introduction
1.1: Summary
Coordinated smooth muscle contraction serves a critical role in both visceral
tissues and in the vasculature where it contracts rhythmically and functions to maintain
muscle tone. Signaling at the myosin filament initiates ATP hydrolysis leading to actin
filament sliding and ultimately force production from the smooth muscle. The
modulation of force output from contraction has been studied in vascular tissues, where
actin bound regulatory elements have been identified as key mediators of muscle tone
(Wang 2001, Smolock et al. 2009, Katsuyama et al. 1992). In particular, the actin
binding protein Caldesmon (CaD) has shown a unique ability to fine-tune contractile
force in smooth muscle tissue. CaD’s role in force modulation has been well documented
at the level of actomyosin interactions, but its functional relevance in coordinating
contraction and tissue maintenance in vivo remains unknown. Our lab has previously
shown that when endogenous myosin activation is perturbed, through inhibition of light
chain (MLC) phosphorylation, intrinsic actomyosin interactions persist raising the
question of whether CaD is able to modulate contraction independently of MLC
phosphorylation. We therefore hypothesize that CaD is capable of controlling contractile
tone irrespective of myosin activation and to test this we have devised an in vivo assay to
monitor smooth muscle tone within the larval zebrafish intestine.
In addition to the many key regulatory elements that initiate or fine-tune smooth
muscle contraction, specific domains within the myosin protein also have profound
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effects on contractile output. At the myosin head, the motor domain tightly coordinates
actin binding, ATP hydrolysis and the release of ADP/Pi. Each ATP-dependent
movement by a myosin dimer along actin requires orchestrated changes in critical
structural domains and mutations in certain protein regions can affect contraction in
unique ways. Both activating and loss-of-function mutations of myosin have been
implicated in human vascular disease and cardiomyopathies, but the mechanism of
smooth muscle dysfunction remains unclear. We have previously characterized a unique
gain-of-function mutation of smooth muscle myosin (myh11) in a zebrafish mutant,
meltdown (mlt). The myh11 mutation resulted in constitutive ATPase activity of the
protein and a striking cellular invasion phenotype was observed in the intestinal epithelia
of mutant larvae, leading to the question: How can altered contraction dramatically
change the cell behavior in an underlying tissue?
Additional evidence from mlt, including abnormal CaD function, has led us to
hypothesize that the myosin mutation leads to increased contractile force and alters the
stiffness of the underlying stromal layer. According to this model, the altered tissue
stiffness in mlt provides a mechanical cue to epithelial cells, which then respond by
initiating cellular invasion. To address this we have examined the crosstalk between the
smooth muscle and epithelial layer in mlt mutants and have performed biomechanical
assays to better understand the link between the contractile defect and epithelial invasion.
In addition to biomechanical signaling, mlt also raises the question of how specific
myosin mutations elicit altered contractile force and if abnormal contraction is a common
defect in human disorders caused by myosin variants. We further hypothesize that
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multiple myosin protein domains are capable of regulating contractile force output
through altered ATPase activity, and that these changes can lead to physiological effects
similar to what we have observed in mlt. To test these hypotheses, we performed a
genetic modifier screen in the mlt background where we set out to shed light on the
signals that link the contractile defect with epithelial invasion. Ultimately, we discovered
additional regions of MYH11 that are also able to propagate the invasive phenotype and
this enabled us to further our understanding of myosin domains in both contractile force
modulation and their potential link to disease states.
1.2 Smooth Muscle Contraction
The proper functioning of diverse tissue types ranging from the vasculature and
respiratory system to the digestive tract and reproductive organs all rely on coordinated
smooth muscle contraction. Depending on the tissue type the nature of this contraction
can be quite different. In the vasculature for example, smooth muscle contracts tonically
permitting slow, sustained contraction during the modulation of vascular tone. Tonic
contraction specifically allows smooth muscle to maintain constant force for a prolonged
period of time with little energy utilization. In contrast, intestinal contraction occurs
phasically with rapid contraction and relaxation to enable food to be propulsed through
the gut at a steady rate allowing for nutrient absorption and expulsion of waste. In each
of these types of contraction, subtle differences occur in the myosin heavy chain and light
chain resulting in distinct contractile patterns and kinetics. The changes that occur on
myosin and its regulatory components have long been appreciated and additional
modulatory factors have been identified that act at the myosin or actin filament to further
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regulate smooth muscle contraction. However, given the diverse functional properties of
each smooth muscle tissue the precise coordination between myosin, actin, and their
regulatory elements remains poorly understood in vivo.
1.2.1 Initiating Contraction at Myosin
In smooth muscle, force is generated by coordinated interactions between actin
and myosin, where cross-bridge formation and cycling is a tightly regulated process. This
is largely due to the N-terminal ends of myosin heavy chains as they form globular heads
that hydrolyze ATP and enable binding to smooth muscle actin. As a result of myosin’s
enzymatic ability to hydrolyze ATP it serves as the primary force generating protein in
smooth muscle. Smooth muscle myosin is made up of two heavy chains and two
corresponding light chains that are physically associated to the head domain. The primary,
regulatory MLC is considered the central activator of smooth muscle myosin, and if MLC
phosphorylation is blocked through inhibition of its kinase (MLCK) normal contraction
cannot proceed. A second light chain protein, the essential light chain, is also directly
bound to the myosin heavy chain, but its role in regulating protein function is less clear
and therefore the regulatory light chain is generally considered the primary regulatory
protein of smooth muscle contraction.
In smooth muscle, contraction initiates in response to Ca2+-dependent MLCK
activity, with additional Ca2+-independent kinases contributing as well. As the primary
initiator of contraction, MLCK becomes active in response to its interaction with the
calcium-binding protein Calmodulin following an influx of cytoplasmic Ca2+. These
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signaling events lead to MLC phosphorylation, which initiates cross-bridge cycling
between myosin and actin leading to contractile force production. In order to maintain
contractile tone in smooth muscle, the phosphatase of MLC counteracts MLCK activity,
providing a balance of MLC phosphorylation and dephosphorylation between individual
myosin heads. This balance of phospho-MLC is especially critical for tissues such as the
vasculature where small changes in contractile tone can ultimately lead to severe
consequences, such as hypertension due to altered smooth muscle contraction.
There are four isoforms of mammalian smooth muscle myosin (Myh11); two Cterminal splice isoforms (SM1 and SM2) and two head domain splice isoforms (SM-A,
SM-B) and different combinations have distinct expression in smooth muscle tissues. A
mouse mutant of SM-B has normal physiology and survival but displays a significant
decrease in maximal force generation and velocity of smooth muscle shortening (Babu et
al. 2001). Relative to SM-A, SM-B contains an extra seven-residue insert that resides in
a domain adjacent to the ATP-binding pocket of the myosin head and its expression is
specific to the intestine, small arteries, and bladder smooth muscles. In vitro motility
experiments have shown that the seven-residue insert can alter the kinetics of the crossbridge cycle and generate higher ATPase activity. Interestingly, knock out mice in which
all myh11 isoforms are deleted display low levels of contraction during early gut
development due to a compensatory effect of non-muscle myosins, an effect dependent
upon developmental timing as the myosin knockout is eventually lethal (Morano et al.
2000). Although smooth muscle myosin is well understood for its importance during
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contractile force production, the specific contributions of each protein domain as well as
interacting, modulatory factors in diverse smooth muscle tissues remains elusive.
1.2.2 Modulating Contraction at Caldesmon
As the primary regulation of contraction, MLC is physically associated with the
neck domain of individual myosin heads (Kamm and Stull 1985, Murphy 1989) and
MLCK phosphorylation induces a conformational change in myosin that activates its
ATPase. ATP hydrolysis induces cross-bridge cycling within the actomyosin complex
and ultimately the generation of contractile force. Interestingly, in ex vivo tissues and
culture cells where phospho-MLC levels are greatly reduced, endogenous actomyosin
interactions are able to generate and sustain low-level smooth muscle contractile force
(Siegman et al. 1984, Haeberle et al. 1985, Gerthoffer 1987, Moreland and Moreland
1987). To account for this, it has been proposed that contraction is also regulated by
actin binding proteins that alter actomyosin interactions independently of phospho-MLC
(Gusev 2001).
One actin binding protein that has been extensively studied for its regulatory role
in smooth muscle is Caldesmon (CaD) (Sobue et al. 1981). CaD exists as two
predominant isoforms that are generated by alternative splicing of a single mRNA
transcript (Kordowska et al. 2006). The low molecular weight isoform (l-CaD) is
expressed in most cell types, including at low levels in smooth muscle, where it mediates
actin and non-muscle myosin interaction in the cortical cytoskeleton (Helfman et al.
1999). The high molecular weight isoform (h-CaD) is expressed specifically in smooth
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muscle and is distinguished from l-CaD by the presence of a peptide spacer domain that
is functionally not well understood, but is thought to facilitate structural rearrangements
of h-CaD (Wang et al. 1991). Interestingly, in an h-CaD knockout mouse it was observed
that l-CaD expression levels increased in intestinal and bladder smooth muscle pointing
to a compensatory mechanism by the light isoform in certain smooth muscle tissues
(Morano et al. 2000).
Binding of h-CaD to the phosphorylated actomyosin complex reduces contractile
force by inhibiting myosin ATPase activity (Szpacenko et al. 1985, Horiuchi et al. 1986,
Earley et al. 1998), possibly by restricting myosin binding to actin or by stabilizing a less
active configuration of the actin filament (Ansari et al. 2008) (Figure 2.1A, based on
prior model (Wang 2001)). h-CaD’s inhibition of the smooth muscle actomyosin
complex can be reversed by Erk-mediated phosphorylation or through its interaction with
Calmodulin in the presence of calcium (Smith and Marston 1985, Ikebe and Reardon
1990, Childs et al. 1992). This results in increased contractile force by enhancing myosin
binding to actin (Katsuyama et al. 1992) (Figure 2.1B) which in turn may stabilize an
active configuration of the actin filament (Ansari et al. 2008). In smooth muscle with
low levels of phospho-MLC, phospho-h-CaD is thought to promote the interaction
between non-phosphorylated myosin heads and actin (Horiuchi and Chacko 1989)
(Figure 2.1C, D). Taken together, h-CaD provides an additional mode of contractile tone
regulation in smooth muscle in the presence or absence of the primary signaling event at
MLC.
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1.2.3 Contractile Regulation of Gut Motility
Myosin activation relies on neural signaling that results in MLC phosphorylation,
and in the gastrointestinal tract (GI tract) the enteric nervous system (ENS) provides this
initial stimulus. The way in which ENS stimulation initiates smooth muscle contraction
is through a Ca2+-mediated signaling cascade that activates Calmodulin, which then
triggers MLCK, culminating in increased phospho-MLC. In the GI tract ENS-dependent,
coordinated contraction is critical in order to process food, absorb water and nutrients,
and expel waste. The smooth muscle tissue layers of the gut are innervated allowing for
coordinated contraction that causes intestinal contents to be mixed and eventually moved
through the intestine. GI smooth muscles are autonomous in that they possess an ability
to generate low-level spontaneous rhythmicity and contraction that can be driven by
intrinsic pacemakers called interstitial cells of Cajal (ICC). Therefore, smooth muscle
cells (SMCs) in the GI tract have the ability to independently contract, though without
electrical and mechanical coupling between cells coordinated contraction and peristalsis
cannot occur (Sanders et al. 2012). Additional inputs from enteric motor neurons are
required in the GI tract to generate coordinated and rhythmic contractions. There are also
two types of muscle cells in the GI tract, circular and longitudinal, each providing
contractile force in different directions and thus requiring fine coordination to produce
rhythmic movements. Coordinated motility in the GI tract is required for efficient
digestion and absorption of food and relies on the interplay between each of the factors
listed above as well as the intrinsic activity of individual muscle cells.
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One example of the autonomous activity of SMCs is highlighted in the small
intestine. In this region of the GI tract, pacemaker activity organizes the spontaneous
contraction of individual cells into phasic contraction, a process that does not depend on
neural inputs. Although this basal activity within SMCs is able to generate low
amplitude spontaneous contraction, neural inputs are required to heighten the strength
and rhythmicity of contractions. In smooth muscle cells, the primary regulators of such
spontaneous contraction are the ICC. In cardiac smooth muscle, pacemaker cells are only
detected in distinct sites, however in the GI tract they form networks of cells throughout
the entire tissue suggesting a more prominent role. The importance of the ICC was
underscored in experiments on cultured gastrointestinal SMCs that alone do not generate
electrical rhythmicity, but upon adding ICC exogenously spontaneous rhythmicity occurs
that resembles intact smooth muscle. Additional studies determined that slow wave,
basal electrical rhythm originates in ICC and that they are coupled to SMCs, allowing the
signal to be transmitted (Dickens and Morris 1998, Cousins et al. 2003, Kito and Suzuki
2003). These observations are consistent with ICC expression throughout the GI tract
where they are able to coordinate contraction and are key in regulating gut motility
patterns. Physiological studies have shown that mice with defective c-Kit signaling,
which is critical for ICC rhythmicity, have a reduced contractile response after neural
stimulation and GI motility defects (Ward et al. 1994, Burns et al. 1997, Beckett et al.
2007). The ENS and ICC represent two well-studied examples of the tight coordination
required across multiple cell types to produce rhythmic GI motility. In addition to
understanding the interplay between neural and pacemaker cells within smooth muscle, it
is essential to comprehend how these inputs translate at the level of actomyosin
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interactions and contractile force. By improving our understanding of myosin motor
function and smooth muscle modulators in vivo, we can begin to comprehend the
complex nature of physiological events such as GI motility in greater detail.
1.3 Motor Mechanism of Myosin
In all forms of myosin, the primary site of activation is the myosin head domain.
Each head can be divided into two regions: the motor domain (i.e. actin activated
ATPase), and the lever arm, an extended helix containing calmodulin-binding sites.
Adjacent to the head domain is a large coiled-coil region that is important for
dimerization and folding of myosin. More than 35 classes of myosins have been
discovered, each with subtle variations of each domain that dictate subtle differences in
protein function. Additionally, myosin proteins may have either one or two heads,
depending on the specific interactions that occur with the binding partners of each type of
myosin.
In the absence of actin, myosin heads retain the ability to rapidly hydrolyze ATP,
but product release requires actin interaction. After inorganic phosphate (Pi) and ADP
are released, ATP rapidly rebinds to the actin-bound myosin, causing dissociation from
actin. All types of myosins maintain this same basic kinetic cycle, but the rate of
transition between each state is highly variable allowing for kinetic tuning of myosin.
Kinetic tuning occurs by altering the rate at which myosin proceeds through the ATPase
cycle and also the relative amount of the cycle that myosin spends in force-generating
states (strong actin binding) (De La Cruz and Ostap 2004). The ratio of myosin’s
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occupancy of the strong states to that of the weak+dissociated+strong states is known as
the ‘duty ratio’ and is often used as a metric of force production from myosin. Since the
rates of Pi and ADP release dictate myosin ATPase cycling, they ultimately determine the
duty ratio also. In the example of skeletal muscle myosin, which functions in large
clusters, a low duty ratio is maintained to maximize the shortening velocity and power
output. The low duty ratio allows this particular myosin to spend most of the cycle
weakly attached or completely detached from actin to prevent drag when strongly bound
heads slide the actin filament. In other types of muscle and in different tissues the
myosin duty ratio can be vastly different depending on the force requirements in each
setting.
Additional features of the myosin protein were revealed after the high-resolution
structure of the myosin head was elucidated in chicken fast skeletal myosin (Rayment et
al. 1993, Rayment et al. 1993). An initial observation of the structure revealed the
presence of a large cleft in the middle of the myosin head which was thought to close
when myosin discards Pi and ADP upon strong binding to actin (Yengo et al. 1998,
Coureux et al. 2003, Volkmann et al. 2003). Another feature of the initial myosin
structure was the location of the myosin light chains, which were bound to the C-terminal
portion of the motor domain. This region is also thought to form a lever arm that can
amplify small movements within the rest of the myosin head. This idea is referred to as
the ‘swinging lever arm’ hypothesis and has been shown to be important in myosin’s
function (Furch et al. 1999, Tyska and Warshaw 2002, Huxley 2007). This hypothesis
adds a level of complexity to how myosin head movements produce contractile force and
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highlights how alterations in each myosin protein domain indeed has the potential to
change the force output.
1.3.1 Phosphate (Pi) Release
As mentioned above, the initial interaction between myosin and actin triggers the
release of Pi and in the absence of actin this release is quite slow. For actin-activated Pi
release to proceed, a ‘back door’ mechanism was first proposed whereby a Pi escape
route could be created through a conformational change of myosin. Though the specific
conformation of this back door is disputed, it is clear that in order for the Pi to dissociate
there must be re-arrangement of either the Switch I or Switch II domain which, along
with ADP, block dissociation of Pi. It is still unclear exactly how each Switch element
can be induced to move after actin binding of myosin, but a mechanism in which Switch I
shifts aside to create the back door is currently favored. Multiple studies have observed
movements of the upper portion of the myosin motor domain, and this has been
interpreted as evidence for Switch I movement being responsible for these movements
(Rosenfeld and Sweeney 2004, Kintses et al. 2007). The concept of Switch I movement
creating the back door is also derived from previous work confirming that Switch II
movement is coupled to movement of the lever arm and thus is an unlikely candidate for
controlling Pi release. Evidence has also implicated Switch I in controlling the position
of the lever arm, suggesting it is able to rearrange and create the Pi release pocket without
altering myosin conformation.
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1.3.2 Myosin Dimers
As an additional layer of complexity with myosin activity, heads of the same
dimer are able to communicate with one another in a process known as ‘gating.’ When
the heads communicate they can coordinate events such as the number of steps a dimer
takes along an actin filament before dissociating. The communication is a response to
strain that occurs when the leading head binds to actin and begins its powerstroke, but is
then prevented from completing the powerstroke due to its connection with the lagging
head. Once the rear head releases ADP, it binds ATP and dissociates from actin to
become the new leading head. While the new leading head searches for a binding site on
actin, the new rear head transitions from strong ADP-binding to weak binding, the
slowest step in the ATPase cycle. This allows time for the leading head to bind, release
Pi, and establish strong binding to actin in order to continue the movement along the
filament.
It is clear that both myosin heads do not bind simultaneously during force
generation, though the second head can increase the displacement or powerstroke of the
engaged head (Tyska and Warshaw 2002). It has been shown in the case of myosin II
that additional myosin heads rapidly attach in response to stretch activation and it is
thought that these heads are indeed the lagging, unattached heads. The stretch
presumably creates a type of physical distortion of attached myosin II molecules that
positions the second head for rapid attachment to actin. This could provide an
explanation of how stretched muscle can rapidly increase its force to resist the stretch
(Brunello et al. 2006). In addition, the force-velocity relationship of muscle can be better
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understood because as the velocity of shortening increases, fewer myosin heads are
attached to actin in a force generating state (Piazzesi et al. 2007). Interestingly, it has
been demonstrated that the force per attached myosin head remains constant irrespective
of velocity. Therefore, one explanation for a decrease in force with increasing velocity
would be a corresponding decrease in myosin heads attached to actin. It has also been
appreciated that phosphorylation at MLC is only required for activation when the myosin
dimer is in tact as a single head of myosin can contract independently of MLC
phosphorylation. In considering myosin function, it is necessary to take into account the
complexity of the individual movements as well as their interaction with neighboring
heads.
1.3.3 Myosin Mutations In Disease
Mutations in smooth muscle myosin have been linked to a number of vascular
diseases, and thus far the most studied of these is the aneurysm and dissection of the
thoracic aorta. Thoracic aortic aneurysms tend to be asymptomatic and often are not
diagnosed before an aortic dissection occurs. However, thoracic aortic aneurysms
leading to acute ascending aortic dissections (TAAD) can be very serious and often cause
premature deaths. A subset of patients with TAAD present with the disease and do not
have an identified genetic syndrome but have relatives similarly affected, and this is
known as familial TAAD. In both sporadic and familial forms of TAAD, mutations in
smooth muscle components have been identified and are implicated in the progression of
the disease. Although both smooth muscle actin and myosin mutations have been

	
  

	
  

14	
  	
  

	
  

identified in patients with TAAD, the implications of these mutations on contraction
remains an outstanding question.
By contracting in response to blood flow, smooth muscle cells (SMCs) regulate
both flow and pressure in the vasculature. Heterozygous mutations of smooth muscle
actin (ACTA2) and myosin (MYH11) are together responsible for TAAD disease in 1014% of families (Guo et al. 2007, Pannu et al. 2007, Zhu et al. 2007). A large French
family with TAAD associated with patient ductus arteriousus (PDA) was used to identify
the defective gene as MYH11 (Khau Van Kien et al. 2005), and subsequent analysis from
three unrelated families with TAAD associated with PDA identified MYH11 mutations in
two of the three families (Pannu et al. 2007). The MYH11 mutations identified for the
familial TAAD/PDA phenotype are limited to four mutations: a small deletion, a splice
site mutation, and two missense mutations. Individuals with ACTA2 or MYH11
mutations can also present with occlusive vascular disease of the aorta due to increased
numbers of SMCs (Pannu et al. 2007).
1.4 Meltdown Mutant and Mechanotransduction
1.4.1 Meltdown Mutant and Smooth Muscle Myosin
Previous work in our lab characterized mlt as a gain-of-function mutation of
MYH11 that results in constitutive ATPase activity at the myosin motor domain. The mlt
missense mutation, W512R, occurs at the rigid relay loop domain that has previously
been implicated in motor activity due to its proximity to critical myosin domains
(Wallace et al. 2005). Physiologically, the constitutive ATPase activity in mlt leads to
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abnormal, tonic contraction as time-lapse imaging revealed intestinal contraction
beginning, but not rhythmically resting and constricting as is seen in wild type larvae
(Seiler et al. 2012). Tonic contraction of this nature could indeed be responsible for
increased force production by the smooth muscle layer upon the surrounding stroma, and
our previous work showed the blocking contraction, by actin knockdown, was sufficient
to rescue the epithelial invasion in mlt. Epithelial invasion can also be induced in
heterozygous mlt, which are otherwise wild type and survive to adulthood, by treatment
with a contractile agonist suggesting that contractile force is the primary driver of the
phenotype. Finally, premature phosphorylation of h-CaD was detected by Western blot
in mlt mutants just prior to the onset of the phenotype (Seiler et al. 2012). h-CaD has
been studied in detail for its ability to alter contractile tone, and at an early time when the
larval zebrafish intestine has very little contractility, h-CaD could certainly cause
substantial changes in force output. Taken together, myosin-induced contractile
abnormalities have the potential of triggering mechanical signals between the muscle and
stromal layer and a better understanding of how this occurs remains and outstanding
question.
1.4.2 Mechanotransduction
The structural framework in SMCs is composed of the contractile unit along with
cytoskeleton (made up of nonmuscle actin and intermediate filaments), which links to the
cell surface through a protein called filamin A (Small and Gimona 1998). Interestingly,
filamin A mutations lead to a syndrome of joint laxity and aortic dissections, suggesting
that it may provide a link between SMC contraction and disease. Filamin A enables the
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actin filaments of the contractile unit to interface with the cytoskeleton at the cell surface,
which contain integrin receptors. Integrins provide the primary signaling to the ECM and
serve as a transmembrane link between the matrix, the actin cytoskeleton, and contractile
units (Moiseeva 2001). This cellular complex, termed the ‘mechanotransduction
complex,’ provides the interface between the contractile machinery on the interior of the
SMC and the ECM on the exterior, to which force is transmitted.
In the vasculature, electron microscopy of the mouse aorta has revealed that SMC
contractile filaments link to microfibrils in the ECM early in development and these
contacts are maintained up through adulthood (Davis 1993). Fibrillin-1 (FBN1) is the
major protein component of these microfibrils, raising the possibility that the integrin
receptors of the ECM may interact with fibrillin-1. Hence, FBN1 mutations may also
disrupt SMC contraction by interfering with the SMC mechanotransduction complex.
Interestingly, in FBN1 mouse mutants the first ultrastructural abnormality noted is an
unusually smooth surface of the elastic laminae, likely due to the loss of cell attachments
that are normally mediated by FBN1 (Bunton et al. 2001).
Taken together, these components link SMC contraction to ECM components that
can alter the stiffness of tissue. Tissue stiffness has been appreciated during tumor
progression where it can predict the presence of a tumor or the development of pathology
with a heightened risk of malignant transformation, yet the relevance of tissue rigidity to
tumor pathogenesis has been largely ignored (Khaled et al. 2004). Though breast cancer
patients with fibrotic “stiff” lesions have a poor prognosis (Colpaert et al. 2001), the
relationship between tissue rigidity and tumor behavior at the molecular level is unclear.
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Tumor rigidity likely reflects an elevation in interstitial tissue pressure due to matrix
stiffening linked to fibrosis (Paszek and Weaver 2004). However, it is not understood if
and how tissue stiffness can actively promote malignant transformation as many current
models rely upon three-dimensional culture assays and physiological forces are likely
quite different from these substrates.
1.5: Research Summary
Our previous work on the mlt mutant has revealed clear roles for increased
contractile force, from myosin and h-CaD, in signaling to the epithelium to initiate
invasion. However, there is a limited understanding of how contractile force production
and epithelial invasion occur in vivo. h-CaD has been studied in great detail in vitro and
in dissected vascular tissue, but a greater understanding of its role in vivo remains to be
seen. Studies on vascular smooth muscle disorders have revealed that diverse myosin
domains can lead to disease progression, and in some instances this is due to altered
motor function. Though mouse models of these vascular disorders have been studied, the
specific contribution of these myosin mutations on altered contraction and the
propagation of the vascular phenotype remains an open question. Cell invasion has also
been linked to altered tissue stiffness, but such studies have relied on advanced threedimensional culturing methods and there is a paucity of in vivo studies on invasion.
In order to model the role of myosin and h-CaD during a normal physiological
process, we utilized the larval zebrafish intestine to observe smooth muscle contraction in
real-time. This allowed us to assay the specific contributions of each contractile protein
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in a live vertebrate. Since h-CaD has been strongly associated with force production
from smooth muscle, we hypothesized that altering h-CaD’s normal function would result
in changes in propulsive peristalsis within the intestine. In Chapter 2, I describe the
consequences of h-CaD knockdown in both wild type larvae and a mutant that lacks
endogenous smooth muscle signaling at MLC. As MLC phosphorylation is the primary
activating signal in smooth muscle, this study was important in understanding h-CaD’s
potential independent role in the process. In Chapter 3, I describe our efforts to
characterize the role, in both smooth muscle contraction and epithelial invasion, of two
myosin mutations that we identified from a genetic modifier screen of mlt.
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Chapter 2: Smooth Muscle Caldesmon Modulates Peristalsis In Vivo
and is Required to Induce Epithelial Invasion in meltdown∗

2.1: Introduction
Previous work from our lab identified a potential role for smooth muscle
Caldesmon in the progression of the epithelial invasion we observed in meltdown (mlt)
mutants. To better understand the contractility of smooth muscle in mlt, Western blot
analysis was conducted on regulatory proteins involved in contraction (Seiler et al. 2012).
Initially, phosphorylated myosin light chain (p-MLC) expression was assayed and found
to similar between wild type and mlt suggesting that this mode of signaling was intact in
mutants. This is consistent with the previous observation that there is unregulated,
constitutive ATPase activity in the mutant Myh11 protein, in that it does not respond to
MLC phosphorylation (Wallace et al. 2005). However, when regulation of the h-CaD
protein was assayed, Western blots indicated that premature phosphorylation of h-CaD
was occurring in mlt. The phosphorylated h-CaD was detected at 72 hpf in mutants,
which is a stage prior to the onset of peristaltic contractions and also when epithelial
invasion initiates in mlt. These observations are consistent with the hypothesis that
resting smooth muscle tone is increased in the intestine of mutant larvae. Outside of its
role in propagating the phenotype in mlt, we also wanted to gain insight into h-CaD’s
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  

	
  The text of this chapter has been published (Abrams et al. Smooth muscle caldesmon modulates peristalsis
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physiological role in vivo as prior studies of this protein have focused on isolated smooth
muscle tissue and individual cells.
By measuring contractile force changes in cultured aortic smooth muscle cells,
multiple studies have shown that the inhibitory activity of h-CaD can indeed modulate
resting tone of individual cells (Lee et al. 2000). These observations were extended to
whole tissue studies of contractile force in dissected aortic tissue after h-CaD siRNA
knockdown (Smolock et al. 2009). These groups reported the reversal of h-CaD
inhibition after knockdown resulting in a net increase in contractile force. These findings
point to h-CaD as a critical mediator of contractile force independent of primary myosin
activation (via MLC phosphorylation), but analysis of h-CaD during physiological
processes in vivo have yet to be elucidated. Our lab has previously shown similarities
between the zebrafish and mammalian intestinal smooth muscle and enteric nerve
patterning (Wallace et al. 2005, Seiler et al. 2010). These conserved aspects of the
zebrafish intestine along with its optical clarity during gut development allowed us to
directly test the role of h-CaD in vivo during a physiological process: intestinal peristalsis.
The high molecular weight isoform of the Caldesmon (h-CaD) regulates smooth
muscle contractile function by binding actin and modulating cross-bridge cycling of
myosin heads. Though the primary regulatory mechanism in smooth muscle occurs
through myosin light chain (MLC), h-CaD may have the ability to enhance contractile
tone independently of MLC regulation. Upon phosphorylation, h-CaD undergoes a
conformational shift allowing myosin binding to occur in a ‘higher energy’ or ‘poised’
state (Figure 2.1). In homozygous meltdown (mlt) mutants, premature phosphorylation of
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h-CaD occurs during a time in intestinal development where phospho-MLC levels remain
low. We hypothesized that phosphorylated h-CaD was responsible for an increase in
smooth muscle contractile tone in mlt and was required for inducing epithelial invasion.
To test this hypothesis we further investigated the role of h-CaD in mlt mutants and in
addition examined its more general role in vivo during intestinal peristalsis. We
performed morpholino knockdown in viable heterozygous mlt larvae and determined that
perturbing h-CaD could induce epithelial invasion in these larvae. To determine whether
h-CaD knockdown could alter intestinal peristalsis we examined live larvae using a
fluorescent gut motility assay. Analysis of these larvae determined that h-CaD protein
was indeed modulating contractile tone in smooth muscle, as had been suggested from
previous work in vitro.
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Figure 2.1: Simplified Model of h-CaD Function. Smooth muscle contraction depicted
by sliding of actin (green) on myosin (red) filaments following ATP hydrolysis, derived
from previous model (Wang 2001). (A) In smooth muscle with high levels of phosphoMlc (p-Mlc), non-phosphorylated h-CaD restricts binding of myosin heads to the actin
filament such that force generation is inhibited. (B) When h-CaD is phosphorylated the
myosin heads are able to bind the actin filament in a manner that enhances actomyosin
interaction (b). This leads to increased force generation (distance b > distance a). (C) In
smooth muscle with low p-Mlc, non-phosphorylated h-CaD prevents binding of nonphosphorylated myosin heads to actin. (D) phospho-h-CaD promotes binding of the nonphosphorylated myosin heads to actin, thereby enhancing contraction; (distance d >
distance c). Distances a, b and c, d are not drawn to scale.
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2.2: Results
2.2.1: Altered h-CaD Function Induces Epithelial Invasion in mlt
At the onset of epithelial invasion in homozygous meltdown (mlt) mutants,
smooth muscle signaling via p-Mlc is just beginning in the developing intestine at 3 dpf
(Seiler et al. 2012). Interestingly, we have detected high expression of total CaD protein
at this early timepoint with markedly low levels of p-CaD expression. This observation
suggests a role for endogenous CaD as a contractile ‘brake’ within the nascent intestinal
smooth muscle (Figure 2.1C, D). Phosphorylation of CaD reverses its inhibition and
enables propagation of contractile force, and interestingly we found that this
phosphorylation occurred prematurely in mlt (Seiler et al. 2012). It is important to note
that low levels of p-MLC expression were also detected at this stage of development,
which implies that coordinated contractions have not yet initiated in the intestine. Since
contraction is just beginning in 3 dpf mlt larvae, the effects of altered CaD function could
become more evident in the absence of mature, coordinated contraction. We postulated
that since phosphorylation of CaD reverses its inhibitory function then morpholino
knockdown of total CaD protein would mimic this block of inhibition by removing the
protein completely.
To investigate the role of h-CaD on the mlt phenotype, we utilized a splice
blocking morpholino (Cald1a-i4e5 MO, refer to Figure 2.7) that enabled us to reverse hCaD inhibition in smooth muscle. Using heterozygous mlt larvae, we injected Cald1ai4e5 MO into one-cell embryos and assayed for intestinal abnormalities that resembled
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the mlt phenotype beginning at 3 dpf. We observed a phenotype in the mid-intestine of
Cald1a-i4e5 MO injected heterozygous mlt larvae that resembled abnormal ruffling of the
intestinal folds (typical of homozygous mlt) compared to normal morphology in Cald1ai4e5 MO injected wild type larvae (Figure 2.2A,C). Age matched Cald1a-i4e5 MO
injected wild type larvae displayed normal intestinal morphology, though they had
decreased gut motility as described later in this chapter. To determine if the phenotype in
mlt heterozygotes induced epithelial cell remodeling and basement membrane
degradation, we performed histological analysis using antibody labeling of basement
membrane (anti-laminin) and epithelial cell junctions (anti-cytokeratin). After antibody
labeling of whole mount larvae at 6 dpf, we embedded and prepared serial sections of
heterozygous mlt with an observable phenotype. Histological analysis revealed
abnormalities that resembled homozygous mlt whereby intestinal epithelial cells were
observed invading into the surrounding stromal layer after basement membrane
degradation (Figure 2.2D). Morpholino injected wild type larvae never displayed
abnormal epithelial morphology and this was also true of heterozygous mlt injected with
a control morpholino (Figure 2.2B).
As h-CaD has previously been described in vitro to modulate contractile force,
these results implicate a role for increased force from the muscle layer to which epithelia
are sensitive. We have shown previously that the mutated Myh11 protein in mlt has
constitutive ATPase activity that is thought to contribute to an increase in contractile
force (Wallace et al. 2005). Our current results show that heterozygous mlt are also
sensitive to increased contractile force, suggesting that there may be a biological
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threshold of force that intestinal epithelial cells are sensitive to. In other words, by
removing h-CaD inhibition in mlt heterozygotes the overall output of contractile force
becomes large enough to induce epithelial invasion (for model, see Figure 3.1).
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Figure 2.2: h-CaD Disruption in Heterozygous mlt Induces Epithelial Invasion. (A)
Live image of 74 hpf wild type (WT) larvae after injection with a morpholino targeting
the large isoform of Caldesmon (Cald1a-i4e5 MO). Cald1a-i4e5 MO has no affect on
WT intestinal morphology other than mild developmental delay (B) Histological crosssections through the intestine of larvae immunostained for laminin (green) and
cytokeratin (red) show normal epithelial architecture in WT. (C) Heterozygous mlt larvae
display abnormal intestinal morphology in the mid-intestinal region after Caldesmon
knockdown. (D) Epithelial invasion (arrowhead) and stratification (asterisk) are observed
in the mid-intestinal region of the mlt heterozygote by histological analysis.
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2.2.2: The Zebrafish Contains Two Caldesmon Gene Paralogs with High Sequence
Homology to Human CALD1
To identify a zebrafish h-CaD ortholog we first performed BLAST analyses of the
zebrafish genome assembly using human CALD1 coding sequence. Two loci encoding
genes with relatively high sequence homology to CALD1 were identified on chromosome
4 and chromosome 25 (cald1a and cald1b, respectively). The predicted protein encoded
by the cald1a locus had the greatest degree of homology to human CALD1, particularly
in the actin and myosin binding domains (Figure 2.3A).
We also compared syntenic relationships surrounding the cald1a and cald1b loci
with human CALD1. We first identified the map positions of the zebrafish orthologs of
65 genes immediately surrounding human CALD1 (Figures 2.3B and 2.4). Of 34 genes
located 5’ of CALD1, 26 were located in a comparable position with respect to the cald1a
locus, whereas only 6 mapped to a comparable position with respect to cald1b. For 31
genes 3’ of CALD1, 14 were located surrounding cald1a whereas none were located
adjacent to cald1b. Next, we performed the reciprocal experiment and mapped the
position of the human orthologs of genes surrounding the two zebrafish cald1 loci. 12 of
40 genes 5’ of cald1a but only 7 of 38 genes 5’ of cald1b mapped to comparable regions
of CALD1. Similarly, 9 of 43 genes 3’ of cald1a but only 3 of 38 genes 3’ of cald1b
mapped nearby CALD1. Paralogs for 17 zebrafish genes were identified in the region
surrounding the two cald1 loci (Figure 2.4).
All together, these findings argue that cald1a and cald1b are gene paralogs that
arose from a whole genome duplication that occurred in an ancestral species of ray	
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finned fish (Amores et al. 1998). We predicted that the Cald1a protein was likely a
functional ortholog of human CALD1 protein based on amino acid sequence homology,
and due to more highly conserved gene synteny surrounding the cald1a locus.
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Figure 2.3: Zebrafish Smooth Muscle Caldesmon (h-CaD). (A) Schematic
representation of the human, chicken and zebrafish h-CaD orthologs. Conserved protein
domains and percent amino acid homology are indicated. (B) Conserved syntenic
relationships surrounding the human CALD1 locus on chromosome 7 and the zebrafish
cald1a locus on chromosome 4. (C) RT-PCR showing amplification of the full-length
cDNA corresponding to the high and low molecular weight zebrafish cald1a isoforms
from intestinal cDNA. A correctly sized transcript for the predicted low molecular
weight cald1b isoform is also detected. (D) Western blot showing intestinal levels of
CaD isoforms. Molecular weight standards indicated. Mb - megabase; Kb – kilobase;
dpf – days post-fertilization.

Figure 2.4: Conserved Gene Synteny Surrounding the Human CALD1 and
Zebrafish cald1a and cald1b Loci. Schematic depicts the genes surrounding the CALD1
locus on human chromosome 7. Genes with zebrafish orthologs in a comparable location
surrounding the cald1a or cald1b loci are depicted in green and orange, respectively.
Gene paralogs surrounding both the cald1a and cald1b loci are listed below.
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2.2.3: Cald1a Encodes High and Low Molecular Weight Isoforms Generated By
Alternative Splicing
The cald1b locus encodes an l-CaD-like ortholog that was previously reported to
play a role in cardiovascular development (Zheng et al. 2009). Genomic sequence
analysis of this locus did not identify a potential h-CaD transcript nor did BLAST
analysis of the zebrafish EST database. To determine whether an alternatively spliced hCaD mRNA transcript was encoded by cald1a, we amplified its full-length cDNA from
whole 5 day post-fertilization (dpf) larvae that have functional intestinal smooth muscle.
Our primers amplified only a fragment corresponding to the predicted low molecular
weight cald1a isoform (data not shown). When the same primers were used to amplify
RNA recovered from dissected intestines (that were enriched for smooth muscle) a higher
molecular weight band was recovered in addition to the low molecular weight band
(Figure 2.3C). By contrast, amplification of intestinal cDNA using comparable primers
from the cald1b ortholog only amplified low levels of a corresponding low molecular
weight band (Figure 2.3C). DNA sequence analysis showed that the larger band
amplified from cald1a encoded a predicted h-CaD ortholog that included an 86 amino
acid spacer domain. Genomic DNA analyses indicated that the spacer was encoded by
two short exons, 36 and 225 base pairs (bp), respectively. We observed only limited
amino acid homology with spacer domains from other vertebrate h-CaD proteins (Figure
2.3A and 2.5). This was expected, as the spacer sequence of h-CaD is not highly
conserved across species. Outside of the spacer domain, the h-CaD cDNA sequence was
identical to the full-length cald1a cDNA, although a splice variant involving the terminal
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exon was infrequently detected (Figure 2.6). These findings show that the cald1a locus
encodes two alternatively spliced transcripts that are orthologs of the mammalian l-CaD
and h-CaD isoforms.
To determine whether the h-CaD transcript encoded a functional protein we
performed Western blot analysis of 5 dpf intestinal extracts using an antibody directed
against mouse CaD protein. This antibody detected both high and low molecular weight
bands (Figure 2.3D). The high molecular weight band was first detected around the onset
of peristaltic contractions (~ 78 hours post-fertilization; data not shown) when only
circular smooth muscle is present (Wallace et al. 2005) and CaD protein levels increased
between 4 dpf and 6 dpf. At these later stages longitudinal smooth muscle develops and
peristaltic contractions are more pronounced. The estimated molecular mass of the high
molecular weight band (125kD) was notably greater than the predicted h-CaD molecular
mass (70kD). However, a comparable discrepancy between predicted and observed
molecular mass of mammalian h-CaD proteins has been reported and attributed to its
large number of acidic amino acids (Bryan 1989). The molecular weight of the
presumptive l-CaD protein was similarly affected.
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Figure 2.5: High Homology at Function Domains in Vertebrate h-CaD Proteins.
Note high degree of conservation in the actin and myosin binding domains (blue lines and
green lines, respectively). H_sapiens – Human; G_gallus – Chicken; cald1b – zebrafish
paralog (chromosome 25); cald1a – zebrafish paralog (chromosome 4).

2.2.4: h-CaD Expression in the Zebrafish Intestine is Restricted to Smooth Muscle
h-CaD expression has been shown in other vertebrates to be restricted to smooth
muscle, whereas l-CaD is ubiquitously expressed. RNA in situ hybridization using an
isoform specific zebrafish h-CaD probe showed only low level background staining in 5
dpf larvae (data not shown). Therefore, to assay h-CaD expression in intestinal smooth
muscle, we recovered epithelial cell and smooth muscle cell RNAs from bigenic larvae
that express cell type specific fluorescent reporters (Figure 2.7A). These larvae express
GFP from the smooth muscle sm22a promoter beginning at 72 hours post-fertilization
(Seiler et al. 2010) and mCherry from a miR194 promoter fragment that is activated in the
epithelium at nearly the same time. RT-PCR amplification of established epithelial
(fabp2, vil11, and fabp6) and smooth muscle (acta2, myh11) markers confirmed purity of
the sorted cell populations (Figure 2.7B). The RT-PCR experiments also confirmed that
zebrafish h-CaD expression was restricted to smooth muscle while l-CaD was expressed
in both smooth muscle and epithelial cells (Figure 2.7C).
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Figure 2.6: Schematic of a Carboxy-Terminal Splice Variant of cald1a. Based on
sequencing analysis, the most common cald1a isoform was comprised of 15 exons (top)
while a minority splice variant isoform contained an additional exon containing a
premature stop codon (bottom).

Figure 2.7: Expression of the Zebrafish h-CaD Ortholog in Intestinal Smooth
Muscle. (A) Scheme to isolate intestinal smooth muscle (green) and epithelial (red) cells
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from Tg(sm22a:GFP; miR194:mCherry) larvae. Fluorescent image of a 5 dpf bigenic
larval intestine is shown. (B) RT-PCR amplification showing expression of intestinal
smooth muscle and epithelial markers in sorted cells. The myh11 primers amplify a band
(*) from contaminating genomic DNA (confirmed by sequencing). (C) Expression of the
high molecular weight cald1a transcript is restricted to smooth muscle. Infrequently an
additional band was amplified from smooth muscle that migrated near the low molecular
weight cald1 transcript (^), however this was detected in only a minority of experiments.
Schematic indicates the location of PCR primers (arrows) in exon 3 and exon 6 that were
used to amplify the cald1a isoforms. e - epithelial; m - smooth muscle.

2.2.5: h-CaD Modulates Propulsive Intestinal Peristalsis in the Larval Zebrafish
To investigate zebrafish h-CaD function in vivo, we generated a cald1a splice
blocking morpholino (Cald1a-i4e5 MO) that enabled us to specifically disrupt h-CaD
translation without affecting translation of the l-CaD isoform. The specificity of Cald1ai4e5 MO also prevented any disruption of the normal function of cald1b. It was crucial
not to disrupt l-CaD function as this isoform is predicted to be essential for a wide range
of non-muscle phenotypes. For this study, we designed a morpholino complementary to
the exon 5 splice acceptor of the h-CaD pre-mRNA (Figure 2.8A). This was predicted to
generate a novel Caldesmon transcript that encoded only 12 of 87 h-CaD spacer region
amino acids.
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Zebrafish embryos and larvae injected with Cald1a-i4e5 MO had normal
morphology other than mild developmental delay that was also seen in control larvae
(Figure 2.8B). In RT-PCR experiments using intestinal RNA and primers surrounding
exons 4 and 5, a fragment of the truncated h-CaD transcript that lacked exon 5 but
retained exon 4, and the fragment corresponding to l-CaD were both amplified (Figure
2.8C). The truncated h-CaD transcript, which was 36 bp larger than endogenous l-CaD
transcript, encoded 12 amino acids in-frame with exon 6. Successful inhibition of
translation of the h-CaD transcript was confirmed by Western blot (Figure 2.8D). This
showed reduced intensity of the band corresponding to h-CaD with increased intensity of
a band corresponding to l-CaD. The apparent increase in l-CaD protein detected by this
blot is likely due to the presence of the truncated h-CaD protein generated by the Cald1ai5e5 MO (as it is only 12 amino acids longer than endogenous l-CaD).
To determine if h-CaD knockdown affected smooth muscle contraction we
assayed propulsive peristalsis in the intestine of larvae injected with Cald1a-i5e5 MO that
were then fed fluorescent microspheres (Figure 2.8E). Following their ingestion, the
microspheres form an aggregate in the intestinal bulb as a result of mixing peristalsis.
This aggregate is then transported into the mid and posterior intestine via propulsive
peristalsis, and eventually expelled. We measured peristalsis beginning at 4 dpf in
Cald1a-i5e5 MO injected larvae by monitoring fluorosphere movement 2 hours after
ingestion. As shown in Figure 2.8E, Cald1a-i5e5 MO larvae had an increase in intestinal
transit as more larvae in this group had moved fluorospheres into the mid-posterior
intestine and/or expelled them. To confirm that contractile rate was unchanged in these
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larvae, video recordings of morpholino injected larvae showed that the rate of peristaltic
contractions was unaffected by h-CaD knockdown (Figure 2.9, top). The affect on
peristalsis was less pronounced at 5 dpf than at 4 dpf, most likely due to the transient
nature of the morpholino knockdown. In addition, because levels of phospho-h-CaD
have increased by 5 dpf (Davuluri et al. 2010), the overall level of inhibition imparted by
endogenous h-CaD is likely to be reduced. Together these data indicate that the normal
function of h-CaD is to negatively regulate the force of phasic intestinal smooth muscle
contraction, as gut transit is accelerated in the larvae injected with Cald1a-i5e5 MO
without a concomitant effect on contractile rate.
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Figure 2.8: h-CaD Deficiency Enhances Intestinal Peristalsis in Zebrafish Larvae.
(A) Schematic depicting isoform specific targeting of the high molecular weight cald1a
transcript by a splice blocking morpholino (Cald1a-i4e5 MO). The exon 5 splice
acceptor is targeted (*). (B) Normal morphology of 4 dpf larvae injected with Cald1ai4e5 MO and a control morpholino. (C) RT-PCR of intestinal cDNA from Cald1a-i4e5
MO larvae using exon 3 and 6 primers (arrows in panel 3A) shows reduced expression of
the high molecular weight cald1a transcript. (D) Western blot using intestinal protein
from Cald1a-i4e5 MO larvae shows reduced levels of h-CaD with slightly increased lCaD levels. Increased l-CaD expression likely reflects an additional protein translated
from a modified transcript only 12 amino acids larger than l-CaD. (E) Images of live 5
dpf larvae that ingested fluorescent microspheres located in anterior and mid – posterior
intestine, respectively. Color scheme in bar graph depicts bead location indicated in
lateral image of larva (lower panel). Cald1a-i4e5 MO larvae show increased propulsive
peristalsis at 4dpf (chi-square test, *** - p<.001). 5dpf p-value = .08, likely due to
transient effect of morpholino knockdown.
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Figure 2.9: Contractile Rate Remains Unchanged in Larvae After h-CaD Disruption.
Cald1a-i4e5 MO and Tg(sm22a:CaDDK51-GFP) larvae in wild type and colourless
backgrounds. Contractions were counted using live video imaging, t = 2.5 min. Number
of larvae assayed and age (dpf) is indicated for each group. Error bars indicate standard
deviation. Tg - Tg(sm22a:CaDDK51-GFP); wt – wild type.
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2.2.6: Interference with h-CaD Binding to Smooth Muscle Myosin and Actin Enhances
Intestinal Peristalsis
h-CaD tethers myosin and actin filaments through interactions with its N- and Cterminal domains, respectively (Ikebe and Reardon 1990, Wang et al. 1997). The h-CaD
- smooth muscle myosin interaction can be disrupted in vitro by expression of a peptide
fragment from the myosin-binding domain common to l-CaD and h-CaD (Lee et al.
2000). By inhibiting endogenous h-CaD binding to myosin, actin-myosin interactions are
enhanced, thereby increasing basal contractile tone (refer to Figure 2.1). A comparable
effect has been reported with a peptide derived from the CaD actin binding domain (Zhan
et al. 1991, Katsuyama et al. 1992).
We generated a transgenic line, Tg(sm22a:CADDK51-GFP), with stable smooth
muscle expression of a zebrafish ortholog of the mammalian myosin binding peptide
(CADDK51). By generating a transgenic line, it enabled us to assay h-CaD function in
older zebrafish larvae that have a developed enteric neuromuscular system with robust
signaling via p-Mlc. This was not possible in larvae injected with Cald1a-i5e5 MO as its
inhibitory effect on translation is transient. In addition to the cDNA encoding the peptide,
the expression vector used to generate the transgenic line encoded GFP downstream of a
viral 2A recognition motif (Provost et al. 2007). This allowed us to identify fluorescent
smooth muscle cells expressing the CADDK51 peptide following its cleavage from GFP.
F0 larvae that had mosaic smooth muscle expression of CADDK51 under control of the
zebrafish sm22a promoter and F1 germline transgenic progeny with ubiquitous intestinal
smooth muscle GFP expression were both viable (Figure 2.10A). Variable transgene
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expression was detected in F1 larvae, most likely resulting from position effects due to
the independent insertion sites of the transgene into the F0 germline. F1 transgenic larvae
were used to further investigate the in vivo function of h-CaD in intestinal smooth muscle
during later developmental stages.
The effect of CADDK51 on h-CaD - myosin filament interaction was examined
by measuring levels of h-CaD bound to smooth muscle myosin protein (Myh11) in the
transgenic larvae (Figure 2.10B). Because h-CaD remains bound to Acta2 in the
actomyosin complex, transgenic larvae were injected with a morpholino targeting smooth
muscle actin protein (Acta2) for this immunoprecipitation experiment. This allowed us
to determine the effect of CADDK51 on h-CaD - myosin interaction independent of
Acta2 interaction. Indeed, Western blot analysis revealed that significantly less h-CaD
bound to Myh11 in Acta2 deficient larvae compared with control transgenic larvae. This
observation supports binding of CADDK51 to Myh11 and subsequent displacement of
endogenous h-CaD.
To determine the effect of CADDK51 peptide on smooth muscle contraction in
vivo we assayed intestinal peristalsis in the transgenic larvae. Using the intestinal
fluorosphere assay (4 hour feeding; assay 4 hours later), we found a significant increase
in the propulsive peristalsis of 6 dpf transgenic larvae compared to non-transgenic
siblings. This increased peristalsis was determined by transport of fluorospheres to the
mid-posterior intestine and their expulsion (Figure 2.10C). When larvae were sorted
prior to bead feeding based upon the intensity of GFP expression, we were able to show
that increased propulsion was dose dependent as GFP expression levels, which are a
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surrogate for the level of CADDK51, correlated with changes in intestinal propulsion
(Figure 2.10D). Importantly, increased intestinal propulsion in transgenic larvae was not
related to altered contractile rate (Figure 2.9, middle). To confirm this affect we also
disrupted actin binding and generated a second transgenic line, Tg(sm22a:CaDMG101GFP), with smooth muscle expression of an inhibitory peptide derived from the h-CaD
actin binding domain (Zhan et al. 1991). The CaDMG101-GFP peptide also had a
pronounced enhancing effect on intestinal motility similar to the CADDK51 peptide
(Figure 2.10C).
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Figure 2.10: Expression of a Peptide Blocking h-CaD - Myh11 Interaction Increases
Intestinal Propulsive Peristalsis. (A) Lateral images of live 5 dpf F0 and F1 Tg(sm22a:
CaDDK51-GFP) larvae showing mosaic and widespread smooth muscle GFP expression,
respectively. (B) IP-Western blot confirms that CaDDK51 myosin binding domain
peptide blocks interaction of h-CaD with Myh11. Total intestinal protein was IP’ed with
Myh11 antibody and blotted as indicated. (C) Bar graph shows increased propulsive
peristalsis in unsorted Tg(sm22a: CaDDK51 -GFP) larvae and Tg(sm22a: CaDMG101 	
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GFP) larvae, in which peptides block h-CaD interaction with myosin and actin,
respectively (chi-square test, *** - p<.001). (D) Enhanced peristalsis in Tg(sm22a:
CaDDK51 -GFP) larvae correlates with the level of transgene expression (determined by
GFP fluorescence). Images show larvae with strong, medium and weak GFP expression
(Fisher’s exact test, ** - p<.05). -MO – control larvae; Acta2-MO – larvae injected with
smooth muscle actin morpholino; -ab - control IP without antibody; Myh11 - smooth
muscle myosin.

2.2.7: h-CaD Modulates Endogenous Smooth Muscle Contraction Independent of
phospho-Mlc
To address the role of thin filament regulation of intestinal peristalsis independent
of phospho-Mlc, we utilized a zebrafish mutant, sox10 colourless (cls), that lacks enteric
nerves (Kelsh and Eisen 2000, Dutton et al. 2001). In previous work, we showed that cls
mutants have nearly undetectable levels of intestinal phospho-Mlc and phospho-h-CaD,
but normal total h-CaD levels. Surprisingly, though cls larvae had little if any intestinal
phospho-Mlc, they had a significant amount of residual peristaltic activity (Davuluri et al.
2010). This suggested that peristalsis was driven by smooth muscle contraction arising
from intrinsic actomyosin interactions. Also, low phospho-h-CaD levels in cls suggested
that baseline peristalsis was inhibited and may be enhanced by h-CaD disruption. To
determine if the lack of phospho-h-CaD inhibited peristalsis in the absence of neuronal
input, we repeated the Cald1a-i4e5 MO experiments in cls mutant larvae (Figure 2.11A).
As in the Cald1a-i4e5 MO wild type larvae, intestinal motility in cls was assayed at 5 dpf
	
  

	
  

45	
  	
  

	
  

because of the transient effects of the morpholino knockdown. Because of reduced
feeding by the mutants, they were exposed to the fluorospheres for approximately 14
hours and assayed 6 hours later. Indeed, we observed enhanced propulsive peristalsis in
h-CaD deficient cls larvae (Figure 2.11A). While fewer of the Cald1a-i4e5 MO cls
larvae expelled the beads (2%, compared to 21% of wild type larvae), many more had
transported the beads to the mid-posterior intestine compared with control cls larvae (68%
vs. 15%, respectively).
Next, we assayed peristalsis in older (7 and 9 dpf) cls larvae that express the
myosin binding peptide in intestinal smooth muscle. Because these larvae were older
than the morpholino injected larvae, an 8 hour feeding was sufficient. Peristalsis was
assayed 20 hours after feeding because the larvae had ingested a larger amount of beads.
Fluorosphere analysis of these larvae showed that both transport of the fluorescent beads
to the mid-posterior intestine and their expulsion was significantly greater in the
transgenic cls larvae (Figure 2.11B). The increased propulsion in transgenic cls larvae
was not related to altered contractile rate (Figure 2.9, bottom). The peristaltic defect in
cls was not fully rescued by h-CaD disruption, as wild type control larvae at both stages
completely cleared all ingested beads (data not shown). This was expected given that the
enteric nervous system is the primary stimulus for smooth muscle contraction. However,
these findings do show that h-CaD mediated inhibition of intrinsic actomyosin
interactions contributes to reduced intestinal motility in the non-innervated intestine of
zebrafish larvae.
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Figure 2.11: Intestinal Peristalsis is Increased in h-CaD Deficient colourless (cls)
Larvae. (A) Bar graph shows partial rescue of intestinal peristalsis in h-CaD deficient 5
dpf cls larvae. (B) Tg(sm22a: CaDDK51 -GFP) cls larvae show partial rescue of
propulsive peristalsis at 7 dpf and 9 dpf (chi-square test, ***p<.001).
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2.3: Discussion
Although regulation of smooth muscle contraction principally occurs at the
myosin (thick) filament through phosphorylation of regulatory Mlc, a potentially
important role for regulation of contraction at the actin (thin) filament has long been
recognized. However, the physiological importance of this mode of regulation has never
been directly assayed in vivo. Here we show that the smooth muscle actin binding
protein h-CaD regulates intestinal peristalsis in the wild type and non-innervated intestine
of zebrafish larvae. We also provide evidence for h-Cad’s critical role in the epithelial
phenotype in meltdown; where we have observed h-CaD modulates contractile tone in
heterozygous mlt leading to epithelial invasion.
2.3.1: Zebrafish h-CaD Paralogs
The h-CaD isoform we identified arises from alternative splicing of a pre-mRNA
transcribed from cald1a, one of two cald1 paralogs we show are present in the zebrafish
genome. The cald1a locus also encodes an l-CaD isoform expressed in intestinal smooth
muscle. Predicted translation of the h-CaD protein showed high sequence homology of
the actin and myosin binding domains compared with other vertebrate h-CaD proteins.
By contrast, there is less sequence homology between the various spacer domains,
possibly because of its proposed structural role as a charged single α-helix (Mabuchi and
Wang 1991, Suveges et al. 2009). The cald1b locus encodes an l-CaD isoform expressed
at low levels in intestinal smooth muscle that was previously reported to play a role in
vascular development (Zheng et al. 2009). Expression of a cald1b h-CaD ortholog was
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not detected. Together with functional analyses described below, these findings showed
that cald1a encodes the zebrafish ortholog of the h-CaD isoform expressed in mammalian
intestinal smooth muscle. These findings also argue that cald1a and cald1b have nonoverlapping functions in smooth muscle, similar to other zebrafish gene paralogs that
arose from genome duplication events.
2.3.2: Caldesmon’s Role in Intestinal Peristalsis and Vascular Tone
We examined the role of h-CaD in intestinal peristalsis and smooth muscle
contraction using a previously described simple in vivo assay. Propulsive peristalsis was
increased in h-CaD deficient wild type larvae generated via isoform specific antisense
targeting. Similarly, peristalsis was increased in larvae that express peptide transgenes
designed to interfere with h-CaD binding to either the myosin or actin filament. Because
the rate of smooth muscle contraction was not increased in transgenic larvae, our findings
argue that h-CaD normally functions to inhibit the force of smooth muscle contraction, as
previously reported (Smolock et al. 2009). Whether h-CaD affects contraction velocity
or the distance of contraction in the intestine could not be determined using our methods.
Although these results are consistent with the predicted role of h-CaD in modulating
smooth muscle contractile force from phosphorylated cross-bridges, to our knowledge
they are the first evidence for this phenomenon in vivo. h-CaD deficient mice have been
generated through gene targeting, however the effect of h-CaD disruption on intestinal
motility has not been reported (Guo and Wang 2005). Given the similarities of intestinal
anatomy and physiology in zebrafish and other vertebrates, we would predict a
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comparable effect of h-CaD deficiency on mammalian intestinal motility (Rich et al.
2007, Shepherd and Eisen 2011).
h-CaD function has been studied extensively in vascular (tonic) smooth muscle.
Besides functioning as a brake on contraction arising from phosphorylated myosin heads,
h-CaD is also thought to sustain contractile force generated by non- or de-phosphorylated
myosin heads, thus accounting for force generation at low levels of phospho-Mlc. The
mechanism of this aspect of h-CaD function is not known but it has been postulated to
occur through either physical stabilization of the actomyosin complex, or the cooperative
activation of non-phosphorylated and phosphorylated myosin heads (Albrecht et al. 1997).
This presumably occurs when h-CaD itself has been inhibited, such as occurs with
phosphorylation.
2.3.3: Role of h-CaD Independent of Light Chain Phosphorylation
Whether h-CaD functions comparably in the phasic smooth muscle of the
intestine and colon is not known. Analyses of cls larvae allowed this question to be
addressed in vivo, as cls have nearly undetectable levels of intestinal phospho-Mlc
(Davuluri et al. 2010). Surprisingly, cls larvae retain a significant degree of peristaltic
function, presumably from ENS-independent smooth muscle contraction, which has been
observed in the embryonic mouse and zebrafish intestine (Holmberg et al. 2007, Roberts
et al. 2007, Roberts et al. 2010). In addition to very low phospho-Mlc levels, cls larvae
also have undetectable levels of phosphorylated h-CaD. A low ratio of phospho-h-CaD
to total h-CaD in cls suggests that the basal level of smooth muscle contraction is
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inhibited. Our observations indicate that this is indeed the case as both Cald1a-i4e5 MO
injection and transgenic expression of the CADDK51 inhibitory peptide enhanced
propulsive peristalsis in cls. Although it is difficult to make mechanistic inferences
regarding h-CaD function from this study, our findings are consistent with the idea that hCaD restricts binding of non-phosphorylated myosin heads to actin (Figure 1C), as hCaD knockdown enhances peristalsis in cls mutants that have low levels of p-Mlc. The
knockdown experiments in wild type larvae (high levels of p-Mlc) argue that h-CaD
restricts binding of phosphorylated myosin heads to their preferred site on the actin
filament (Figure 1A) and that this constraint is relieved in the absence of h-CaD.
2.3.4: h-CaD and Human Intestinal Disorders
h-CaD is widely expressed in human smooth muscle and has also been used
extensively as a tumor marker (Miettinen et al. 1999, McCluggage 2004). Its best
characterized physiological role is during pregnancy when total h-CaD levels increase
(Word et al. 1993), thus inhibiting premature stretch induced uterine contraction (Li et al.
2009). At the time of delivery, phospho-h-CaD levels increase dramatically and this is
thought to enhance the force of uterine contractions. A role for premature
phosphorylation of h-CaD in a rodent model of pre-term labor has also been reported (Li
et al. 2004). In addition, recent findings have also implicated CaD (via Sox4 interaction)
in skeletal muscle myoblast differentiation (Jang et al. 2013). In this study, siRNA was
used to reduce CaD expression in myoblasts resulting in decreased cell spreading and
differentiation. Their findings suggested a unique role for CaD where, through its
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interaction with Sox4, it becomes involved in actomyosin organization in myofibrils
during skeletal muscle development.
Relatively little is known about the regulation or function of h-CaD in the human
intestine. In rabbit colonic smooth muscle, h-CaD serine-789 is phosphorylated upon
exposure to the enteric neurotransmitter acetylcholine, which also drives phosphorylation
of Mlc (Somara and Bitar 2006). h-CaD phosphorylation by acetylcholine argues that its
normal function is to enhance ENS-mediated smooth muscle contraction. This further
suggests that in the setting of ENS dysfunction, levels of both phospho-Mlc and phosphoh-CaD are reduced, as occurs in zebrafish cls mutants. Surprisingly, cls larvae retain
peristaltic activity, which is likely a function of smooth muscle physiology and intestinal
anatomy at larval stages. ENS disruption in the adult human intestine, as modeled by
conditional Mlck disruption in mice (He et al. 2008), is predicted to cause irreversible
intestinal motility defects. However, with only a modest reduction in ENS function it is
conceivable that modulation of h-CaD could be used to enhance motility in humans.
Targeting h-CaD could therefore be a therapeutic strategy to treat hypomotility caused by
enteric neuropathies and disorders associated with reduced phospho-Mlc. These
disorders are likely to occur with aging and also related to Cajal pacemaker cells defects
(Somara et al. 2007, Farrugia 2008).
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Chapter 3: Altered Myosin Motor Activity and h-CaD Dysfunction
Propagate Contractile Force and Cause Epithelial Invasion in mlt
3.1: Introduction
An outstanding question remains during the process of cell invasion as to what
signals are responsible for initiating invasion and how such a signal is transmitted from
the surrounding stroma to the cell to trigger invadapodia formation and cell motility.
From our laboratories previous work on the meltdown (mlt) mutant we have mounting
evidence that increased contractile force in the intestinal smooth muscle could initiate
invasion of the underlying epithelial cells (Wallace et al. 2005, Seiler et al. 2012). As the
process of cell invasion had yet to be studied in vivo using a genetic model, we aimed to
utilize mlt as a means to better understand how physical signaling can induce invasion.
To elucidate the molecular signaling occurring in mlt mutants between the smooth muscle
and the underlying epithelial layer our laboratory previously performed microarray
transcriptional profiling. We found a significant increase in the expression of reactive
oxygen species (ROS)-responsive genes and in particular glutathione peroxidase (gpx), a
protective enzyme of oxidative damage was upregulated in the intestinal epithelium.
ROS signaling has been studied extensively for its role in cancer cell invasion
where it can activate both metalloproteinases and epithelial-to-mesenchymal transition
(EMT) genes. To test the importance of oxidative stress in the progression of the mlt
mutant, heterozygous larvae were treated with menadione, an intracellular ROS generator,
and were found to develop an epithelial phenotype comparable to mlt mutant larvae
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(Seiler et al. 2012). Interestingly, the treated heterozygotes did not develop cysts or
epithelial expansion; features which are indicative of the late mlt phenotype. In addition,
ROS treated heterozygotes had increased expression of phosphorylated h-CaD,
comparable to that seen in mlt mutants. Taken together, these observations point to a
crosstalk between the intestinal epithelium (where ROS is produced) and the smooth
muscle, resulting in the propagation of contraction and ultimately epithelial invasion
(Figure 3.1). To test this, we investigated the possibility of a physical signal occurring at
the level of the intestinal tissue by measuring tissue stiffness directly. To shed light on
the interplay between smooth muscle contraction and epithelial invasion, we performed
cell dissociation experiments to establish if crosstalk between the muscle layer and
epithelium is indeed necessary in the progression of the mlt phenotype. The mechanical
signal in mlt was found to be independent of overall tissue stiffness, an observation that
we ascribe to local alterations between the stroma and the basal surface of epithelia. We
also found that it is necessary for each cell type to remain adjacent to one another, as in
the organized intestine, as dissociation of the tissue is sufficient to diminish the signaling
between them.
We have also investigated the importance of myosin motor activity on smooth
muscle contraction and the propagation of the mlt phenotype. The mlt myosin mutation
(W512R) occurs at a conserved region of the motor domain called the rigid relay loop,
and the missense mutation results in constitutive ATPase activity of myosin (Wallace et
al. 2005). A number of unique smooth muscle myosin mutations have been described in
vascular disease, suggesting that altering myosin’s motor function can have widespread
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outcomes in vivo. We therefore performed a genetic modifier screen in zebrafish to
identify additional myosin mutations that can contribute the invasive phenotype in mlt.
Two dominant enhancers of mlt were identified harboring unique mutations in vastly
different myosin domains, the motor region and C-terminal helix. These mutant proteins
work in concert with the mlt mutation to initiate epithelial invasion, presumably by
increasing contractile tone. We therefore provide the first in vivo evidence for these three
distinct myosin mutations sensitizing the intestinal epithelium for invasion, and provide
an initial analysis of additional oncogenic signals and ROS responsiveness in each
genetic background.
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Figure 3.1 Amplification Feedback Signaling Loop Controls Smooth Muscle
Contraction and Invasion in mlt (A) In mlt heterozygotes the expression of mutant
Myh11 protein does not generate sufficient smooth muscle tension to induce epithelial
invasion or stratification (0). Menadione treatment induces ROS production in the
epithelium (1). Epithelial ROS signaling leads to premature phosphorylation of
Caldesmon in heterozygous smooth muscle cells (2). The resulting increase in smooth
muscle tone (3) leads to an amplified ROS response in the epithelium (4), establishing a
feed forward loop causing additional h-CaD phosphorylation and increased smooth
muscle tension. Together these stimuli induce invasive remodeling of the epithelium (5).
(B) Endogenous smooth muscle tone in mlt homozygous larvae (0) induces epithelial
ROS (1) and h-CaD phosphorylation via epithelial signaling (2, 3). Ultimately, this
culminates in epithelial invasion (4), as in menadione treated mlt heterozygotes. Figure
provided by Christoph Seiler and published in Seiler et al. 2012.
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3.2: Results
3.2.1: Smooth Muscle Tension Activates a Feed Forward Signaling Loop That Amplifies
Epithelial Redox Signaling
In homozygous mlt, the activation of redox signaling in the intestinal epithelium
along with the premature phosphorylation of h-CaD during the onset of the phenotype
suggest that there could be crosstalk between the smooth muscle and epithelial tissue.
We have previously tested the nature of this crosstalk by assaying for phosphorylated hCaD in heterozygous mlt larvae that were treated with menadione, an ROS generating
compound (Seiler et al. 2012). These experiments revealed that redox signaling was
indeed altering contractile force through h-CaD, but it was not clear whether it was
signaling from the epithelium or if the menadione treatment had a direct effect upon the
smooth muscle. Initial in situ hybridization experiments suggested that redox signaling
was restricted to the epithelial layer as ROS-responsive genes, such as gpx, were
expressed exclusively in epithelial cells after menadione treatment. These observations
led us to hypothesize that h-CaD phosphorylation in menadione-treated heterozygotes
was triggered by an epithelial signal rather than by a direct effect on the smooth muscle.
To test this hypothesis, we asked whether menadione could induce h-CaD
phosphorylation in dissociated smooth muscle cells from heterozygous mlt, as crosstalk
with the epithelium would presumably be lost after tissue dissociation. Intestines were
dissected from 3 dpf heterozygous mlt and wild type larvae then promptly treated with
trypsin to dissociate the tissue into a suspension of epithelial and smooth muscle cells.
The dissociated cells were then treated with menadione and immediately prepared for
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Western blot analysis. A control group consisting of dissected intestines that were treated
with menadione was used to ensure that redox signaling affected ex vivo tissue in the
same manner as we observed in live larvae. Western blots revealed that indeed h-CaD
phosphorylation occurred in the non-dissociated heterozygous intestines after menadione
treatment, whereas untreated intestines lacked any phosphorylation (Figure 3.2A). In
contrast, phosphorylated h-CaD was not detected in dissociated smooth muscle cells from
heterozygous mlt that were treated with menadione (Figure 3.2B, n = 3 independent
experiments). Importantly, phosphorylated h-CaD was present in dissociated
homozygous mlt smooth muscle cells showing that this form of the protein was not
degraded during the incubation period of the assay (Figure 3.2B, lane 3). These
observations point to crosstalk from the smooth muscle to the epithelium as being an
essential component of the phenotype and thus we next wanted to better understand if
physical signals were being transmitted from the smooth muscle.
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Figure 3.2: Crosstalk Between Smooth Muscle and Epithelium. (A) Western blot
showing premature h-CaD phosphorylation (pCad) in dissected intestines from
menadione treated heterozygotes but not homozygous WT larvae (lane 4 versus lane 3;
ratio phospho-h-CaD WT:mlt = 0.02/1, relative to total h-CaD; CaD; in six experiments
the ratio averaged 0.016/1; p<.001). h-CaD is prematurely phosphorylated in intestines
dissected from 74 hpf mlt homozygotes versus mlt heterozygotes (lane 1 versus lane 2).
(B) Western blot showing h-CaD phosphorylation (pCad) in the menadione treated
heterozygous intestines prior to dissociation (lane 2) but not after dissociation into free
cell populations (lane 5). Phospho-h-CaD persists in dissociated cells from homozygous
intestines (lane 3), but is not detected in control intestines dissected from mlt
heterozygotes, before (lane 1) or after (lane 4) dissociation into free cell populations. No
phospho-h-CaD was detected in any dissociated samples in three independent
experiments. Loading control, phospho-Myosin light chain (pMlc).

	
  

	
  

59	
  	
  

	
  

3.2.2: Distinct Mechanosensory Mechanisms Are Activated in Invasive Cells in Response
to Smooth Muscle Tension
One conceivable outcome of increased contractile force from the smooth muscle
is the stiffening of the extracellular matrix surrounding the intestinal epithelial cells.
Matrix stiffening promotes cell invasion in breast cancer models, in part through
activation of focal adhesion kinase (FAK) (Paszek et al. 2005, Levental et al. 2009) and
we therefore hypothesized that we were observing a similar biomechanical phenomenon
in mlt mutants. To determine whether a comparable mechanical signaling mechanism
was activated in mlt we initially dissociated intestinal tissue and cultured the smooth
muscle cells. Using atomic force microscopy (AFM) we aimed to measure the stiffness
of individual cells, however AFM measurements yielded variable results that were
difficult to interpret (data not shown). We therefore proceeded with whole tissue
elasticity measurements of mutant larvae using a force displacement assay (Levental et al.
2010). For this assay, we utilized freshly dissected intestines and plated tissues on CellTak™, a biological adhesive, to prevent shifting during the measurements. Before
invasive remodeling is detected in mlt (70 hpf), tissue compliance was nearly identical in
mutant larvae and their wild type siblings throughout the range of tissue indentations
tested (Figure 3.3A, n = 6 mlt and 21 wild type larvae). When remodeling is first detected
at 74 hpf, this compliance was slightly increased at the surface of the mlt intestine but
similar to wild type controls at greater tissue depths, the measured difference is
potentially due to the basement membrane degradation that occurs at this stage (Figure
3.3B; n = 7 mlt and 12 wild type larvae examined). Although small changes were
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observed at 74 hpf, force values indicative of significant intestinal stiffening, as would be
predicted from models of breast cancer invasion, were not detected in dissected mlt
intestines.

To assay for changes in extracellular matrix stiffness at the molecular level,
previous work in our laboratory examined the phosphorylation of a known
mechanotransducer, FAK, in mlt using immunohistochemistry (Snow and Henry 2009)
and Western blot analyses. However, neither method detected elevated p-FAK in mlt
(Seiler et al. 2012). Western blots also showed that levels of Collagen-1 and Fibronectin,
additional markers of matrix stiffening, were not significantly elevated in the mlt intestine.
All together, these data argue that mechanical force triggers epithelial invasion in mlt
independently of changes in matrix composition or increases in tissue rigidity. One
possible interpretation is that focal changes in force within the intestinal lumen occur
without a corresponding change in total tissue stiffness. Altered blood pressure has been
observed in smooth muscle disorders within the vasculature, but without available
methods to detect altered force within the intestinal lumen of the larval zebrafish we
cannot know definitively.
Together with the h-CaD morpholino data from chapter 2, these findings support
a model in which h-CaD phosphorylation in mlt smooth muscle cells arises from a ROSactivated epithelial signal (Figure 3.1). Phosphorylation of h-CaD then enhances smooth
muscle tone, thereby generating additional oxidative stress within the epithelium. This
establishes a feed-forward signaling loop with the adjacent smooth muscle that further
enhances contractile tone, amplifies epithelial ROS production, and culminates in
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epithelial invasion. In heterozygous mlt, activating redox signaling allows the epithelium
to increase contractile tone in the smooth muscle through the phosphorylation of h-CaD
that leads to further ROS production and culminates in cell invasion. Removing h-CaD
inhibition directly by morpholino knockdown also increases contractile tone and drives
the epithelial phenotype, further emphasizing the importance of this protein as a
modulator of smooth muscle contraction. These observations raised two important
question that we aimed to address: 1) Since the epithelia in mlt mutants are responding to
altered contractile tone, how can this tone be altered to initiate invasion? 2) How is the
specific myosin mutation in mlt (W512R) contributing to increased contractile tone and
can mutations in different domains of the myosin protein produce a similar affect?
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Figure 3.3: Mechanical Signaling in mlt and Wild Type Intestines. (A) Force
displacement measurements show identical compliance of intestines dissected from mlt
and WT larvae before the phenotype develops at 70 hpf, and a modest decrease in
compliance at the outer surface of the intestine (<4 micron indentation) when invasion is
present at 74 hpf. (B) Compliance is indicated by Young's modulus, which is proportional
to the slope of the Force versus Tissue indentation curve.

3.2.3: Dominant Modifier Screen Identified Two Enhancer Mutants of meltdown
We next sought to gain additional insight into the potential mechanosensory cues
and smooth muscle contractile dynamics that are responsible for the increased force in
the mlt intestine. From our h-CaD and ROS observations, we hypothesized that epithelial
cells in mlt initiate redox signaling in response to changes in the overall force output by
the smooth muscle tissue. If this hypothesis were true we should in principal be able to
find additional mutations within the smooth muscle that alter force output or in epithelial
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components that are sensitive to ROS and mechanical signaling, and to test this we
performed a forward genetic screen for modifier mutants.
We chose to perform a modifier screen due to a number of advantages that
allowed us to better elucidate the critical signaling occurring in mlt. Traditional forward
genetic screens in zebrafish have identified numerous mutants that affect conserved
developmental pathways (Driever et al. 1996) as well as mutants with human disease
phenotypes, however many of the underlying mechanisms are not well understood.
Modifier screens are a useful way to address this and have been used extensively in other
organisms where they have aided in the understanding of major developmental and
regulatory pathways (Jorgensen and Mango 2002, St Johnston 2002). In addition,
traditional genetic screens, from which mlt was initially characterized, relies on
incrossing of the second generation (F2) to produce homozygotes where recessive
mutations are scored by phenotype, but in a modifier setup you can screen one generation
earlier. As a powerful approach to elucidate the mechanisms of know recessive mutants,
modifier screens identify second-site mutations that specifically enhance (worsen) or
suppress (ameliorate) the phenotype of a given mutant (Bai et al. 2011). Traditionally,
the screen is performed in a sensitized genetic background in which the function of a
particular pathway is only partially disrupted and therefore viability of the mutant animal
is not affected. Such a genetic background can be achieved by using a heterozygous
mutant with a haploinsufficient phenotype or a homozygous mutant of a weak allele.
However, due to embryonic lethality and a lack of heterozygous phenotypes most
existing zebrafish mutants are not suitable for modifier screens. Fortunately, from our
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laboratory’s previous work on the mlt mutant we have discovered an inducible
heterozygous phenotype that allows us to use this background for modifier genetics.
From our previous work we know that although heterozygous mlt survive
normally through adulthood, they can develop epithelial invasion as larvae under certain
conditions where ROS is abundant or when gut contraction is exogenously increased
(Seiler et al. 2012). This sensitized heterozygous background in mlt makes it an
attractive mutant for a modifier genetic screen. We first generated our founder (F0)
population by treating adult males in the long-fin wild type background (TLF) with the
chemical mutagen, ENU. Due to the toxicity of ENU, we had two surviving, fertile male
founders out of 50 that were mutagenized from which we derived our screen.
Importantly, we crossed our F0 population with heterozygous mlt adults to
generate an F1 generation consisting of 50% trans-heterozygotes (mlt/ENU mutations)
and 50% heterozygotes for only the ENU induced mutations (Figure 3.4). To screen for
mutants that enhance or suppress epithelial invasion in mlt, we performed a modifier
screen by initially carrying out a genetic cross in the F1 generation between the
mutagenized founder generation and heterozygous mlt adults (Figure 3.4, F1). The
resulting F2 generation contains trans-heterozygote individuals that carry a single mlt
allele combined with the allele carrying the new mutation induced by ENU mutagenesis.
By randomly crossing together F2 trans-heterozygotes, screening can be performed on
two unique mutations in each cross. This crossing scheme also allows for screening of
both enhancers of heterozygotes and suppressors of homozygous mlt (Figure 3.4, F2).
Using this method, screening was performed on more than 1000 unique F1 genomes and
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from this two enhancer mutants were identified that induced a phenotype in the
heterozygous mlt larvae.
3.2.4: Characterization and Sequencing of Dominant Enhancer Mutants
Both modifier mutants caused a generally similar phenotype in the mlt
heterozygote epithelium whereby invasive epithelial cells were observed in the midintestine at 6 dpf. In one mutant we identified, S237Y, the mlt trans-heterozygote
phenotype was observed in a higher percentage of larvae compared to the second mutant,
L1287M. In addition, a subset of S237Y mutants displayed a more severe phenotype in
the mid-intestine (Figure 3.5B). Histological evaluation of trans-heterozygote larvae
from both enhancer mutant backgrounds revealed the hallmarks of epithelial invasion
occurring at 6 dpf, whereby basement membrane degradation coincided with abnormal
epithelial cell motility (Figure 3.5C).
To determine the chromosomal location of each mutation, map crosses were
carried out by mating each F1 mutant adult with a polymorphic wild type background
(WIK). This crossing scheme typically enables large numbers of mapping markers to be
identified due to the presence of a high number of SNPs between the two wild type
strains. However, while performing F2 crosses between adult modifier heterozygotes and
mlt heterozygotes we observed a very strong linkage, where no instances of
recombination were seen in over 400 individuals screened. In other words, we never
observed the mlt mutation and the modifier mutation in the same individual suggesting
tight linkage and a very low recombination frequency.
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Figure 3.4: Dominant Modifier Screen to Identify Enhancers and Suppressors of
mlt. The male parent is mutagenized, such that a subset of its sperm contains a mutant
allele. The mutagenized male is then mated with a heterozygous mlt female. The F1
progeny of this mating were genotyped for heterozygous mlt and mated randomly with
additional mutant progeny. Each F1 contains a unique mutation (i.e. ‘mut1’, ‘mut2’, etc.)
and incrossing these adults allows for multiple mutations to be screened in a single clutch
of F2 larvae. The low number of modifier mutants identified reflects the specificity of the
intestinal phenotype that was screened for. In addition, F1 larvae with a modifier
phenotype may not have survived to adulthood due to the intestinal defects observed.
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From this observation it was reasoned that the mlt mutation and new mutation
(S237Y or L1287M) were either a very small difference apart in their chromosomal
location or were indeed new alleles of myh11. In combination with both modifier
phenotypes being similar in appearance to mlt epithelial invasion, we reasoned that there
was a high likelihood that these mutations were indeed two additional mutant alleles of
myh11. To validate the new mutations and because of their tight linkage with mlt, the
5922 basepair coding region of zebrafish myh11a was sequenced from intestinal cDNA in
each modified trans-heterozygote. Sequence data was analyzed manually and instances
of double peaks were recorded (one peak corresponding to mlt, the other to the new
mutation). Each short nucleotide polymorphism (SNP) identified was compared to the
translated sequence to determine if it resulted in an amino acid substitution or in-frame
STOP codon. From this analysis, we confirmed that both mutants were new myh11
alleles and that both were missense mutations (Figure 3.5E-H). Interestingly, each
mutation occurred in vastly different domains of the Myh11 protein; one at the Nterminal motor domain (S237Y), and the other at the C-terminal coiled-coil tail domain
(L1287M)(Figure 3.5G-H). Given that the mlt mutation, W512R, occurs in a unique
protein domain of MYH11 compared to these two modifier mutants, the new alleles
presented us the opportunity to tease apart myosin function in vivo.
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Figure 3.5: Two Dominant Enhancer Mutants Contain Unique Missense Mutations
on MYH11. (A) Wild type larvae at 6dpf, arrow depicts mid-intestine connecting
anterior and posterior regions (B) mlt mutant larvae at 6dpf, arrow depicts cyst-like
expansion of mid and posterior intestine (C) S237Y/mlt trans-heterozygous larvae at 6dpf,
arrow depicts partial phenotype in mid-intestine. Note normal appearance of anterior and
posterior intestine at this stage. Severe phenotype was observed in a fraction of
S237Y/mlt trans-heterozygotes. Arrows indicated sites of cyst-like expansion that was
only observed in larvae with severe phenotype. (D) L1287M/mlt trans-heterozygotes,
arrows indicate partial phenotype in mid-intestine that was similar to S237Y/mlt. (E+F)
	
  

	
  

69	
  	
  

	
  

Sequencing of the myh11 exome in S237Y/mlt larvae identifies distinct mutations.
Asterisk indicates the location of each mutation where double peak represents the mutant
and mlt alleles at a given locus. (G+H) Both mutations result in missense amino acid
substitutions in Myh11. Arrow indicates affected amino acid on Myh11 for each mutant.

Since we initially observed the trans-heterozygote phenotypes of the modifier
mutants at 6 dpf, where invasion was present in the mid-intestine, we wanted to
determine if epithelial cells initiated a response earlier in development. Smooth muscle
contraction begins to organize at 3 dpf, and this is when the phenotype in homozygous
mlt is first observed, therefore we wanted to assay for invasion at this timepoint in the
trans-heterozygotes. As no morphological changes were observed in the intestine at this
stage, we utilized a transgenic line, Tg(miR194:Lifeact-GFP), in which a GFP-labeled
peptide that binds F-actin (Lifeact-GFP) is expressed in the intestine (Seiler et al. 2012).
By crossing Tg(miR194:Lifeact-GFP) into the modifier mutant background we could
visually score for invadopodia in these larvae by cross-section analysis. To do this we
immunostained wild type and trans-heterozygous larvae with antibodies against laminin
and GFP and found that protrusions localized to sites of extracellular matrix degradation,
and that epithelial cells invade the surrounding stroma through sites of degraded
basement membrane (Figure 3.6C,D). Whereas in wild type Tg(miR194:Lifeact-GFP)
the basement membrane remains in tact and no actin-rich protrusion were observed
(Figure 3.6A,B).
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3.2.5: S237Y, A Myosin Switch I Mutant Affecting Motor Function
Recent work on myosin V has determined that a protein domain termed ‘switch II’
plays a critical role in stabilizing the conformation of the nucleotide-binding pocket in the
presence of actin (Trivedi et al. 2012). The same group also demonstrated, by mutation
analysis of the switch II domain, that the region is essential for communication between
the active site on myosin and the actin-binding region, which is required for ATP-induced
dissociation from actin. A proximal domain, ‘switch I’, has been shown to cooperate
with switch II to maintain the proper structural alignment that enables release of Pi
through the ‘back door’ of the myosin active site (Lawson et al. 2004). Mutagenesis of
amino acids within the switch I region generally had little affect on ATPase activity,
though certain side chains were able to alter the ATPase binding pocket (Shimada et al.
1997). A neighboring serine was also mutated in myosin II (S237C) in Dictyostelium
discoideum that was shown to cause defective ATP hydrolysis upon binding to actin
(Cochran et al. 2013). The homologous serine in myosin V was mutated (S217A) and
shown to slow both actin-activated ATP hydrolysis and reduce the duty ratio, a measure
of how long myosin spends in strong actin-bound states (Forgacs et al. 2009). Switch II
was also shown to be critical in mediating a key conformational change in the nucleotidebinding pocket that leads to the release of ADP. Additional mutations in the switch I
domain of smooth muscle myosin (F344W and F248W) showed increased basal ATPase
activity (Robertson et al. 2005, Decarreau et al. 2011). A hearing loss-associated
mutation in myo1c was also found to be located at the start of the switch I domain
(R156W). This mutation was shown to inhibit actin-activated ATP hydrolysis and had a
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lower duty ratio that was attributed to a slowed rate of phosphate release (Lin et al. 2011).
Structural changes in switch I are also thought to be tightly coupled to the strength of
actin-myosin interaction (Kintses et al. 2007). Interestingly, the homologous tryptophan
(W501) in Dictyostelium discoideum to that which is mutated in mlt (W512) has been
implicated in probing the movements in the switch I and switch II domains and the
interplay between these domains may very well alter ATP hydrolysis or ADP and Pi
release (Zeng et al. 2004, Malnasi-Csizmadia et al. 2005). Taken together, this myosin
domain has a strong link to myosin’s motor function and has structural implications that
would enable it to interact with the helix loop helix domain in mlt.
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Figure 3.6: Invadopodia Formation in the Invasive Epithelial Cells of the S237Y/mlt
Trans-Heterozygotes. (A,B) Histological cross-sections through the intestine of 74 hpf
immunostained wild type larvae. Basement membrane is labeled in red (laminin
immunostain) and actin labeled green (GFP immunostain in Lifeact-GFP transgenics).
Nuclei labeled by DAPI (blue). In wild type no actin-rich regions are observed adjacent
to the basement membrane. (C) Actin rich protrusions, indicating invadopodia formation,
in S237Y/mlt co-localize with sites of basal lamina degradation (arrow). (D) During
progression of the phenotype epithelial cells invade the tissue stroma through degraded
regions of the basal lamina (arrow).
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The mutation that we identified in the myosin motor domain, a serine to tyrosine
substitution occurring at amino acid 237, was located within the switch I domain of
Myh11. As noted earlier, this specific region of Myh11 has been shown to play a critical
role in the ATPase function of myosin. The domain forms a pocket out of which ADP
can be efficiently released during ATP hydrolysis, and changes in the amino acid make
up of the switch I or switch II domain can slow the release of ADP during contraction.
Delaying the release of ADP slows the uncoupling of myosin and actin during
contraction, and thus allows the myosin head to remain bound to actin longer. This has
been described previously in Dictyostelium discoideum, as mutation of the homologous
serine, S236, resulted in slowed ADP release and altered ATPase function (Cochran et al.
2013). To test if the MYH11 S237Y mutation altered ATPase function similarly to S236,
in vitro ATPase measurements were performed. For this assay, it was necessary to
introduce the S237Y mutation into a truncated form of the human MYH11 protein
(HMM), as full-length myosins form large filaments in vitro that disrupt ATPase
measurements. The S237Y HMM was transfected into insect cells and exposed to an
increasing concentration of smooth muscle actin to measure ATPase hydrolysis as
described previously (Sweeney et al. 1998). Strikingly, unphosphorylated S237Y HMM
protein displayed a significant increase in ATPase activity when compared to wild type
HMM that only had low, baseline activity due to the lack of pMLC (Figure 3.7A). This
increased ATPase activity was not due generalized activation of the mutant protein, as
phosphorylated S237Y HMM returned to normal levels of ATPase activity comparable to
wild type (Figure 3.7A, phosphorylated).
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In addition to ATPase function, the rate of inorganic phosphate (Pi) release was
examined for the S237Y mutant. This step is considered rate-limiting for the ATPase
cycle and has been shown to be the entry point into force generating states (Sweeney and
Houdusse 2010). Pi release was faster in S237Y and this increase was not affected by
MLC phosphorylation (Figure 3.7D,E). Additionally, the release of ADP can be
measured as a readout for myosin detachment from actin, as its release limits detachment.
The rate of ADP release was decreased nearly 2-fold in S237Y and also was not affected
by MLC phosphorylation (Figure 3.7B,C). Using these measurements, the duty ratio can
be determined which determines the relative amount of the cycle myosin spends in strong
actin-binding (force-generating) states. As shown in Table 1, S237Y maintains a higher
duty ratio when compared to wild type in the phosphorylated and unphosphorylated states
of myosin. Taken together, these results suggest that MYH11 S237Y protein exits
nonforce generating states faster (higher Pi release) while maintaining force-generating
states longer (slower ADP release) and that the overall force output will increase in the
mutant.
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Figure 3.7: S237Y Mutation Causes Aberrant ATP Hydrolysis In Vitro. (A) Myosin
ATPase assay of heavy meromyosin protein (HMM) harboring the homologous S237Y
mutation in human myosin. Unregulated ATPase activity is detected in
unphosphorylated S237Y mutant protein compared to wild type protein that only shows
baseline activity (compare ⦁ to ▼). Changes in S237Y mutant ATPase activity after
MLC phosphorylation were not detected (compare ▲ to ■). (B-C) Myosin ADP release
assay of S237Y mutant HMM where time is represented on the horizontal axis and
overall fluorescence is depicted on the vertical axis. The release of ADP from
actomyosin is measured using a fluorescently labeled nucleotide and quantifying the rate
at which fluorescence is lost to determine the rate of dissociation. In both phosphorylated
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and unphosphorylated S237Y protein the rate of dissociation was slower (required more
time to decrease fluorescence, also see Table 1). (D-E) The release of Pi from myosin
was measured using a fluorescent probe for Pi based on a phosphate binding protein
(White et al. 1997, De La Cruz et al. 1999) (also see Table 1).

3.2.6: Myh11L1287M, A Myosin Tail Domain Mutant
While the domains within the myosin motor unit have been characterized in some
detail for their role in ATP hydrolysis and actin binding, the coiled-coil tail of myosin is
far less understood. It is known, however, that the charge along the coiled-coil is
important in assembling thick filaments and for structural modification. Myosin tail
mutations have been described in cardiac smooth muscle (MYH7) as being implicated in
dilated cardiomyopathy, but the functional consequences of these mutations are less clear
than those occurring on the motor domain. One possibility is that altered coiled-coil
structure could affect myosin incorporation into thick filaments and indirectly affect force
output over the longer term (Wolny et al. 2013). Wolny et al. tested 6 different MYH7
tail mutations that had been implicated in cardiac disease, and looked at their ability to
form filaments and contract normally using a cell culture assay. They found that
mutations that disrupted α -helical content of peptides also had reduced thick filament
formation in culture, but no changes in contraction were observed. One particular MYH7
mutation at a highly conserved amino acid, E1356K, was found to be thermodynamically
instable, hindering its ability to form filaments (Armel and Leinwand 2010). Two unique
mutations at the same tail domain amino acid (R1500P and R1500W) have been shown to
cause dilated cardiomyopathy, but both cause decreased thermodynamic stability and
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overall filament self-assembly (Armel and Leinwand 2010). These observations suggest
that alterations at the myosin tail domain and its corresponding helical structure can have
the potential to alter motor function indirectly. Importantly, these structural changes at
the myosin rod can lead to tissue-wide defects as it has been demonstrated in cardiac
smooth muscle and is likely the case in other smooth muscle tissues as well.
The C-terminal modifier mutant, a leucine to methionine substitution which
occurred at amino acid 1287, was located in the tail region of Myh11, a protein domain
critical for myosin dimerization and filament formation. The domain forms a coiled-coil,
bringing together individual myosin proteins to form functional dimers, a process
required for actin shortening and thus the production of contractile force. Though we
cannot directly measure myosin dimerization in this context, mutations in this region
have been previously described and altered myosin contractility has been reported.
Myosin tail domain mutations are also known to alter filament assembly of neighboring
myosin dimers, which affects muscle contractility. To determine if the L1287M mutant
had a defect in motor function we aimed to perform an in vitro ATPase assay, however
for this we needed to utilize the full length Myh11 protein as the mutation occurred in the
tail domain. The full length protein has been generated, however these measurements are
currently ongoing.
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Table 1: Increased Myosin Duty Ratio in S237Y Mutant. Values presented are taken
from same experiment shown in graphical form in Figure 3.7

3.2.7: Redox Signaling in L1287M but Not S237Y
Meltdown mutants have increased expression of ROS responsive genes and
heterozygous mlt larvae develop invasive epithelia in response to treatment with ROS
compounds. We therefore wanted to examine redox signaling in the two modifier
mutants. As neither S237Y nor L1287M develop a visible phenotype as homozygotes,
we reasoned that ROS treatment could potentially induce epithelial invasion similarly to
our previous observations in heterozygous mlt. To examine this question, we treated
homozygous S237Y and L1287M mutant larvae with 1.5uM menadione to activate ROS
in the epithelium as previously described (Seiler et al. 2012). Interestingly, we observed
invasive epithelia in 3 dpf homozygous L1287M mutants, this phenotype was similar to
the response seen previously in heterozygous mlt larvae (Figure 3.8). This observation
suggests that two very disparate mutations occurring in Myh11 (W512R and L1287M)
can sensitize the intestinal epithelium to redox signaling, likely through the overall
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contractile output produced by the smooth muscle. Surprisingly, S237Y homozygotes
failed to respond to menadione treatment (data not shown, 3 independent experiments)
pointing to the possibility of subtle differences in force output occurring at each myosin
domain. Age matched heterozygous mlt larvae were included in all menadione
treatments to confirm that redox signaling was active in these experiments and the
developmental timing was correct (Figure 3.8C), as the staging for treatment is crucial to
initiating invasion in mlt. To determine if menadione treatment of homozygous S237Y
larvae initiated intestinal protrusions without cell invasion, we repeated the menadione
treatment experiment in Tg(miR194:Lifeact-GFP). As we have previously reported
instances where invadopodia protrude the surrounding basement membrane without
causing epithelial cell invasion, we postulated a similar phenomenon could be occurring
in menadione treated homozygous S237Y mutant. However, we observed normal Lifeact
GFP expression comparable to that of wild type larvae suggesting that S237Y
homozygous mutants were not even mildly responsive to redox signaling (data not shown,
2 independent experiments).
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Figure 3.8: Oxidative Stress Induces Epithelial Invasion in Homozygous L1287M
Mutant Larvae. (A-C) Lateral images of live homozygous L1287M (A), wild type (B),
and mlt heterozygous larvae (C). Larvae were treated with Menadione for 3 h beginning
at 73 hpf. Menadione treated L1287M homozygous larvae have an intestinal phenotype
(arrows) that resembles an untreated mlt homozygous larvae (Wallace et al. 2005). No
observable phenotype was detected in wild type larvae, and heterozygous mlt were used
as a positive control.
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3.2.8: Normal Intestinal Motility and Survival of Homozygous Modifier Mutants
Homozygous mlt mutants begin developing an intestinal epithelial phenotype at
74 hpf and the cells gradually expand into a cyst-like malformation of the entire gut
preventing the larvae from processing food and hindering their survival. However, since
this lethality is due in large part to the severe epithelial phenotype that disrupts overall
gut architecture rescue experiments were conducted to determine if survival could be
improved. As the mlt mutation is a gain-of-function in Myh11, rescuing the phenotype is
achieved by morpholino knockdown of MYH11 protein (Wallace et al. 2005).
Morpholino knockdown in zebrafish is transient with normal protein expression typically
returning between 5 dpf and 7 dpf. Therefore, contractile function of the mutant Myh11
protein can be monitored in the larval intestine at 7 dpf along with general survival
resulting from the smooth muscle defect, independent of epithelial disorganization. In
rescued mlt mutants, a significant deficit in gut motility was observed when assayed
using a fluorescent bead feeding method. Most rescued homozygous mlt mutants
retained a fluorescent bolus in the anterior gut after being left overnight, whereas nearly
90% of wild type injected larvae had expelled all beads at that time (Fig. 3.9). This result
suggests that the mutant Myh11 protein, a constitutively active ATPase, was unable to
generate rhythmic contractions necessary for gut motility in the developed intestine.
Moreover, time-lapse movies confirmed that only mild contraction was occurring in
rescued mlt, supporting the idea of an unregulated mutant protein lacking coordinated
contraction. When compared to the contractile deficit we see in cls mutants (see chapter
2), rescued mlt show similarly slowed gut motility but contraction is not visually evident
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as it is in cls, highlighting the importance of endogenous actomyosin interactions which
can occur independent of phospho-MLC in cls (Davuluri et al. 2010). The lack of visible
contraction in rescued mlt suggests that the mutant myosin not only cannot respond to
phospho-MLC, but also that endogenous actomyosin interactions cannot contract
normally in the mutant. Not surprisingly, rescued mlt individuals are not highly
successful at surviving into adulthood, as only 2 out of 100 rescued individuals were
viable, but showed decreased body size and small swellings along their ventral side.
To assess contractility in the Myh11 modifier mutants, gut motility was assayed
in homozygous larvae from S237Y and L1287M. Incrossing heterozygous carriers of
each mutant allele never yielded a visible phenotype in the homozygous progeny, so
fluorescent bead feeding assays were performed to monitor any subtle changes in gut
contraction. These assays were performed on all larvae from an incross to assess motility
in both homozygous and heterozygous larvae. In both S237Y and L1287M, we observed
normal gut motility at 6dpf when larvae were assayed 4 hours after removing the beads
and also after an overnight incubation while feeding on paramecia (Figure 3.9). Timelapse imaging of S237Y homozygotes revealed no detectable changes in rhythmic
contractions occurring at 6dpf (data not shown), thus confirming that the ATPase
dysfunction in this mutant was not as physiologically severe as in mlt with regard to
contraction. Additionally, both homozygous modifier mutants are viable throughout
adulthood. It should be noted, however, that a subset of L1287M homozygous adults
display signs of infertility and can become lethal as adults. The near normal survival and
lack of visible contractile defects in homozygous modifier mutants supports the notion
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that mlt heterozygotes remain highly sensitive to modest changes in contractile force and
redox signaling, as single allele of S237Y or L1287M will suffice to induce epithelial
invasion.

Figure 3.9: Normal Intestinal Motility in S237Y and L1287M MYH11 Mutants. (A)
Bar graph represents cumulative results from pooled clutches of S237Y larvae that were
	
  

	
  

84	
  	
  

	
  

fed fluorospheres at 6 dpf and assayed for intestinal motility the following day. The
pooled larvae were derived from a heterozygous incross and contain 25% wild type, 50%
heterozygous, and 25% homozygous S237Y mutant larvae. These graphs represent the
combined data from 3 independent experiments (chi-squared test, *P > .05, not
significant) (B) L1287M larvae pool has a small decrease in intestinal motility at 6 dpf
(chi-squared test, **P < .05). Compare this to WT sibling and rescued mlt -/- bar graphs.
mlt larvae were rescued by injecting myh11 morpholino as described previously (Wallace
et al. 2005). These larvae show nearly 25% having no intestinal motility and serve as a
positive control group (chi-squared test, ***P < .001).

3.2.9: Modifier Mutants are Sensitive to Oncogenic Signaling
Heterozygous mlt and homozygous L1287M mutants respond to menadione treatment at
74 hpf, but at later stages of development this response to ROS signaling is lost. At 5 dpf,
invasion is not observed after menadione treatment in S237Y and L1287M homozygous
mutant larvae (data not shown) and this lack of a response was likely due to a change in
the epithelial redox signaling and smooth muscle contractile dynamics compared to 74
hpf. In heterozygous mlt larvae, our lab previously reported a response to menadione in
older larvae when oncogenic signaling was enhanced (Seiler et al. 2012). Using a
transgenic strain that expresses an activated human KRAS allele in the intestinal
epithelium (Tg(miR194:eGFP-KRASG12V), intestinal epithelial cell hyperplasia was
induced in 5 dpf zebrafish larvae. In addition, these KRAS transgenic larvae were bred
into an axin1 loss-of-function mutant background, which disrupts Wnt signaling and
leads to added intestinal hyperplasia, as described previously (Heisenberg et al. 2001).
The intestinal epithelial cells in these ‘KRAS-axin’ larvae are similar to those in
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colorectal cancers where activated KRAS and defective Wnt signaling both occur. In the
KRAS-axin larvae that were also heterozygous for mlt, menadione treatment at 5 dpf
generated a dramatic invasive response, whereas siblings that were wild type at the
myh11 allele showed no response to menadione (Seiler et al. 2012). To determine if
S237Y and L1287M were sensitized to oncogenic signaling in a similar manner to mlt,
we crossed each mutant into the KRAS-axin background and performed menadione
treatment experiments at 5 dpf. After 5 hours of menadione treatment, both homozygous
myh11 mutants displayed epithelial invasion while heterozygous larvae resembled wild
type (Figure XX). Importantly, invasion was not detected after menadione treatment of 5
dpf homozygous myh11 mutants that lacked KRAS-axin, suggesting that the observed
response was indeed due to oncogenic signaling in these mutants.
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Figure 3.10: Activation of Oncogenic Signaling Enhances Sensitivity of S237Y and
L1287M to Oxidative Stress. (A) Lateral views of live, menadione treated 5 dpf axin
mutant larvae that express mutant KRAS in the intestinal epithelium (Kras-axin).
Hypertrophy of the intestinal epithelium in Kras-axin larva is unchanged by treatment
with menadione. (B) Menadione treatment causes pronounced cystic expansion of the
intestinal epithelium of the Kras-axin S237Y homozygote (arrows). (C-D) Histological
cross-sections through the intestine of immunostained larvae show invasive cells in
menadione treated Kras-axin S237Y homozygotes (arrows). Invasion is not detected in
menadione-treated Kras-axin wild type siblings. (E-F) Similar cystic expansion is
observed in Kras-axin L1287M homozygotes larvae after treatment with menadione
compared to wild type sibling controls.
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3.2.10: Altered Vascular Flow Rate After Smooth Muscle Actin Disruption
In many of the human diseases associated with myosin mutations as well
phenotypes described in mouse models for thoracic aneurysm and cardiomyopathy,
vascular abnormalities remain a common feature. Our findings in the intestinal smooth
muscle show that altered contractility can result in striking features such as epithelial
invasion, and lastly we sought to determine if smooth muscle abnormalities could lead to
vascular phenotypes in zebrafish. We utilized the smooth muscle actin (acta2)
morpholino that we described above in chapter 2 and injected into wild type embryos.
We raised these larvae to 5 dpf, when vascular smooth muscle expression is first detected
in zebrafish and compared the vascular flow rate to age-matched, control injected wild
type larvae. We found a significant increase in both arterial and venous flow in acta2
morphant larvae when compared to control injected wild type (Figure 3.11A). Consistent
with this, the measured artery and vein width was increased in acta2 MO injected larvae
also (Figure 3.11B). Indeed we expect that altered smooth muscle actin function would
decrease contraction in the vasculature allowing for the vessels to widen and pass blood
faster. This proof-of-principle experiment shows that contractile disruptions can indeed
be detected in the vasculature of larval stage zebrafish, presenting this method as a
potential way in which to study smooth muscle contraction in addition to the intestine.
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Figure 3.11: Increased Vascular Flow After Smooth Muscle Actin Disruption. (A)
Artery and vein flow rate was measured in 5 dpf larvae that were injected with a
morpholino targeted to smooth muscle actin (acta2, n=10 larvae) or a mismatched control
morpholino (n=8 larvae). (B) Widening of arterial and venous blood vessels using images
obtained from the same set of larvae assayed in (A). Values are presented as an average
flow rate or average width of all the larvae tested. t-test * P < .05, *** P < .005

	
  

	
  

89	
  	
  

	
  

Discussion
Studies of myosin missense mutations in vascular disease and in vitro analyses of
specific protein domains have provided important links between myosin during
contractile modulation and its potential to cause severe disruptions within certain tissues.
However, the connection between the specific function of myosin and its tissue-wide
effects cannot be realized through these analyses. Our results provide an in vivo analysis
of the role for S237Y, L1287M, and W512R myosin mutations in both smooth muscle
contraction and the propagation of epithelial invasion within the intestine. In our model,
each of these mutations alters myosin contractility in a unique way through the dynamic
process of ATP hydrolysis and each mutant is different in their response to redox and
oncogenic signaling. These results provide a unique avenue with which to study smooth
muscle contractility and they lead to a number of additional questions requiring further
investigation. For one, it would certainly be interesting to determine the precise nature of
the L1287M mutation with regard to its ATPase function and this is something we hope
to gain further insight on in the near future. Overall, our data implicate myosin mutations
and h-CaD in the tuning of contractile tone and alterations in the function of these
proteins can result in striking and biologically interesting disruptions in the GI tract. In
the future, applying these observations to vascular abnormalities in the larval zebrafish
would provide an interesting connection with known human vascular diseases where
Myh11 is mutated.
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Chapter 4: Conclusions and Future Directions
In this work, we have addressed how smooth muscle contractile force can be
modulated as well as the consequences of abnormal contractility in the intestine. We
have revealed an important in vivo role for h-CaD during gut motility, which illustrates a
modulatory function for this protein during contractile force production. In a previously
studied h-CaD knockout mouse, smooth muscle tissues appeared to function normally
and this was attributed to a compensatory role of l-CaD in this context. Thus the ability
to re-examine h-CaD function using the live imaging capability of zebrafish allowed us to
monitor its affect on smooth muscle contraction in the gut. Because of the established
role in vitro for h-CaD in regulating vascular tone, our findings in the zebrafish intestine
may potentially be extended to the vasculature and other smooth muscle tissues as well.
We have also characterized a novel mutation in the myh11 motor domain that leads to
altered ATP hydrolysis and initiates epithelial invasion in heterozygous mlt, a previously
characterized myh11 mutant. A second mutation in the helical tail domain of myosin was
also found to cause invasion in heterozygous mlt and was responsive to redox signaling,
its role in ATP hydrolysis is currently under investigation. Although the tail domain
mutant only responded to redox signaling when homozygous, this observation remains
clinically relevant as our assay is conducted with a fairly short exposure to reactive
oxygen. In heterozygous human carriers, for example, a longer time period of exposure
to reactive oxygen could allow a response to manifest gradually. Taken together, this
work suggests that alterations of specific MYH11 domains and smooth muscle regulatory
elements, such as h-CaD, can have profound effects on both physiological functions and
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biomechanical signaling leading to cellular invasion. In the following section, these
conclusions will be investigated in more detail and additional experiments will be
proposed to further this work in the future.
4.1: Implications of h-CaD as Force Modulator During Contraction
During smooth muscle contraction, a number of contributing factors work in
concert to produce coordinated rhythmicity or maintain muscle tone. The
phosphorylation of MLC has been thoroughly described as the regulatory event initiating
contraction, but to better understand the diverse roles that smooth muscle plays in each
tissue its critical to consider each of the modulatory events which fine tune contraction. It
is now appreciated that clear differences exist between longitudinal and circular smooth
muscle layers as well as their specific neural inputs and these differences can lead to vast
changes in contraction and force output. Prior work from our lab has shown that in a
zebrafish mutant lacking enteric nerves and with no phospho-MLC GI motility persists,
albeit extremely slowly (Davuluri et al. 2010). These observations point to other
contributing factors such as ICC pacemaker activity, hormonal stimulation, intrinsic
actomyosin interactions and modulatory proteins, such as h-CaD being critical in tuning
the force output and rhythm of smooth muscle contraction. We have used a simplified,
readily observable vertebrate system in the larval zebrafish intestine to determine the
roles of h-CaD, phospho-MLC, and enteric nerve input in vivo. However, our analysis
has not determined that these regulatory factors maintain similar importance later in
development or in complex mammalian tissues where additional inputs need to be
considered. Thus, it will be critical to evaluate whether targeting h-CaD in mature tissues
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can generate the same response that we have seen with our observations, as this will shed
light on the potential for modulating smooth muscle contraction in human GI and
vascular disorders.
Additional evidence of CaD’s importance in the regulation of smooth muscle
contraction was recently demonstrated using a mouse model of bladder contraction.
Mice were generated that carried mutations within the CaD ATPase inhibitory domains
and though homozygotes were embryonic lethal, heterozygous mice could produce more
contractile force during bladder smooth muscle contractions (Deng et al. 2013). These
observations point to CaD’s role within diverse smooth muscle tissues as well as the
physiological sensitivity to CaD disruption, as contraction was enhanced in heterozygotes.
Enteric nerve and smooth muscle tissue grafting are widely utilized procedures in cases
where gut motility is disrupted, and both present a number of limitations. CaD and
related smooth muscle regulatory proteins present an alternative mode of contractile
regulation that has the potential to be fine-tuned using targeted strategies.
Both the inhibitory role of h-CaD and the molecular signaling pathways that
regulate its activity have been characterized in smooth muscle cells from the digestive
tract and other mammalian tissues (Gerthoffer and Pohl 1994, Earley et al. 1998, Chacko
et al. 2004, Lu et al. 2006, Zhang and Zhang 2007, Smolock et al. 2009). Despite these
advances in understanding h-CaD function and regulation, its role during complex
physiological responses, such as intestinal peristalsis, has not been directly examined in
vivo. Isoform specific knockout of h-CaD in mice has been reported, however visceral
smooth muscle function was not perturbed due to a compensatory increase in l-CaD in
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phasic smooth muscle tissues (Guo and Wang 2005). A more recent follow up study
found that arterial smooth muscle in h-CaD null mice was abnormally slow at relaxing,
supporting the role of h-CaD in controlling vascular tone (Guo et al. 2013). This
observation suggested that unphosphorylated crossbridges did not properly detach and
importantly, there was no difference in MLC phosphorylation in these mutants indicating
that this change in relaxation is only attributed to the loss of h-CaD. One possible
explanation of the altered relaxation in the mutants is the slow release of ADP during the
myosin ATPase cycle, allowing the dephosphorylated heads to remain attached to actin
longer in the absence of h-CaD before they progressively detach.
4.1.1 Smooth Muscle Contraction and Gastrointestinal Disorders
As discussed in Chapter 2, a potential role of h-CaD in mammalian intestinal
motility could be to compensate for disruptions in enteric nerve signaling where limited
contraction persists, as it would be unlikely to offset a complete loss of MLC
phosphorylation. One context where this would be important is in tissue regeneration and
transplantation efforts where coordinating contraction remains a major hurdle. Initial
tissue engineering approaches of the small intestine that have used transplanted tissue in
rat and canine models of severe bowel resection have shown improvement in the basic
physiology and enteric nerve regeneration (Chen and Badylak 2001, Grikscheit et al.
2004). However, these tissues did not produce the proper coordination of circular and
longitudinal smooth muscle that is crucial to generate appropriate force for gut motility.
Similar challenges have been encountered with stomach and colonic smooth muscle, as
regenerated tissue demonstrated an absorptive capacity but did not respond to stimulation
	
  

	
  

94	
  	
  

	
  

by acetylcholine treatment (Hori et al. 2002). Lastly, three-dimensional in vitro models
have demonstrated that alignment of circular smooth muscle can be achieved around the
colonic lumen and rhythmic contraction can occur, but these findings have yet to be
validated in vivo (Hecker et al. 2005).
One promising study by Pan et al. used neural crest progenitor cells for
transplantation into a rat model for colonic dysfunction. In this study, the authors were
able to demonstrate a partial rescue of neuronal mediated gut motility in the diseased
colon after transplantation (Pan et al. 2011) and previous work has shown that human
enteric progenitor cells can repopulate segments of an aganglionic colon (Metzger et al.
2009). In this example, the results are similar to what we have observed with h-CaD’s
ability to partially rescue motility in colourless mutant larvae that lack enteric nerves. It
would certainly be compelling to analyze h-CaD function in these transplantation studies.
Limited success has also been achieved in studies with engineered sphincteric smooth
muscle, as this region of the GI tract is less complex and therefore easier to induce
motility. Engineered sphincteric smooth muscle tissues grown in culture and grafted into
animals displayed low levels of contractile tone as well as a response to neural input
(Raghavan et al. 2010, Raghavan et al. 2012). However, restoring gut motility has not
been demonstrated in these studies and regenerating smooth muscle layers with proper
orientation and functionality remains a challenge.
As current efforts are focused primarily on enteric nerve replacement or smooth
muscle tissue grafting, targeting regulatory elements in these tissues may allow finer
manipulations of contraction and possibly better muscle coordination. A number of these
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challenges could be addressed in vivo using the zebrafish model of intestinal contraction
that we have established. For example, by using small molecules one could foreseeably
screen for factors that improve or reduce gut motility in the larval intestine. Not only
would such an approach carry the potential to uncover targeted compounds to treat
motility disorders, but also by understanding the target and mechanism of action such
small molecules could provide valuable insight into the regulatory complex guiding
smooth muscle contraction. By furthering our understanding of both actomyosin
interactions and mediators of force production such as h-CaD, and combining this insight
with the current tissue engineering methods, the potential exists to improve coordinated
contraction in GI motility disorders and after tissue replacement therapies.
In summary, smooth muscle contraction and gut motility results from coordinated
behavior of multiple cell types and modulatory factors at the contractile apparatus.
Although much has been elucidated about the function and molecular mechanism of these
different cell types, highly specific therapeutics for GI motility disorders remain elusive.
In each disorder or region of the GI tract, the regulation of contractile force and the
mechanisms that regulate smooth muscle excitability seem to differ considerably. There
are also differences between the GI tracts of mice, humans, and zebrafish although
understanding the specifics of human smooth muscle regulation will start with modeling
the process in other vertebrates. It is also important to consider that motility disorders
may not be manifested throughout the entire GI tract. For example, if constipation results
from hypomotility in the colon that does not imply that other regions of the GI tract will
contract abnormally, and thus treatments devised to increase contraction in one area may
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negatively affect motility in a neighboring region. Importantly, there are many
similarities between the GI tract and other organs (i.e. the vasculature) with regard to
smooth muscle and its regulatory components, and manipulating molecular targets in the
gut could alter contraction of other critical organs. Currently, there are very few gut
specific smooth muscle targets and a limited number of efficacious compounds to treat
motility disorders. Therefore, there is a need to identify additional regulatory elements at
the molecular level that can modulate smooth muscle contraction and GI motility, as
these discoveries would allow for more targeted therapies.
Additionally, in studies of c-kit mutants where ICC are absent contractile
responses could be elicited in the stomach and lower esophageal sphincter after repetitive
stimulation, suggesting that transmitter overflow can elicit a response without ICC
(Sivarao et al. 2001, Huizinga and White 2008). Other inputs from purine interstitial
neurotransmission (PDGFRa) generate an electrically coupled complex that allows SMCs
to become stimulated after activation of any cells within the complex. Layers of
regulation also exist in circulating hormones, paracrine substances and inflammatory
mediators. Altering any of these regulatory inputs can change the response of SMCs
leading to gut paralysis or hypermotility disorders that affect the movements of food,
absorption of nutrients, and waste transit. A greater understanding of the basic
contractile apparatus in gut smooth muscle would provide a foundation for improving
occurrences where upstream signaling has been disrupted. GI motility disorders
commonly arise from developmental defects and disease processes that compromise
function, and regenerative medicine has the potential to correct motility problems through
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engineering of functional GI smooth muscle and enteric nerves. However, the complex
organization and contraction of smooth muscle has presented a challenge in coordinating
tissue-wide contraction. Extensive work on vascular smooth muscle, where differentiated
SMCs have been used to engineer functional tissue, has shed light on the challenges of
providing normal contraction in synthetic tissue. Though fairly successful in vascular
tissue, engineering GI smooth muscle has presented several challenges due to the many
cell types and neural inputs that regulate carefully orchestrated rhythmic contractions
(Bitar and Raghavan 2012). Further studies of both h-CaD and myosin within GI smooth
muscle could aid in avoiding some of the setbacks in transplanting tissue when motility is
disrupted. With the great strides that have been made in tissue engineering and
transplantation, studying contractile modulators could complement this approach when
addressing therapeutic validity for motility disorders.
4.2: Muscle Contraction and Increased Force
Mutations of Myh11 have been implicated previously in vascular disease and in
our studies we have found a connection between smooth muscle mutations and epithelial
invasion in an underlying tissue. In both vasculature disease and in our work in the
intestine, Myh11 mutations alter the motor function that ultimately leads to the abnormal
physiology observed. This observation suggests that smooth muscle contractility has the
capability to dictate the morphology of neighboring cells and underlying tissues. Indeed,
muscle contraction has been shown to order tissue morphology in the skeletal system and
during embryogenesis. Using both a mouse and zebrafish model, Shwartz et al. showed
that chondrocyte morphology during skeletal development was impaired when muscle
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contraction was chemically or genetically reduced (Shwartz et al. 2012). They observed
rounded, rather than elongated, cells in paralyzed zebrafish and in ‘muscle-less’ mouse
mutants impaired chondrocyte intercalation was noted. Contractile force has also been
shown to regulate bone growth earlier during embryogenesis, as mutant mice that lack
muscle contraction harbor offspring with abnormally developed bone structures (Sharir et
al. 2011). In these ‘muscular dysgenesis’ mutant mice it was also observed that
osteoblasts were improperly distributed due to the altered mechanical load from the
muscle layer. While these examples occur in a skeletal muscle system that varies
considerably from smooth muscle, they do point to the importance of muscle contractile
force output in shaping individual cells or even entire tissues. This raises the question of
how altered contractile force can lead to the diversity of phenotypes that have been
reported and epithelial invasion that we have described from our observations. In the
following section I will discuss the described role of myosin in certain disease states and
consider how specific regions of the proteins contributes to certain conditions.
4.2.1: Consequences of Myosin Mutations in Disease
Myosin missense mutations have been well characterized in cardiac smooth
muscle where they are known to cause both dilated and hypertrophic cardiomyopathies,
the two most common forms of genetic heart disease. More than 300 distinct myosin
mutations have been identified in these diseases and are distributed throughout the
protein, though most mutations occurred in the head domain (Buvoli et al. 2008, Walsh et
al. 2010). More detailed analysis determined that regions of the motor domain adjacent
to the ATPase site had a greater frequency of mutations (Moore et al. 2012). Although
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the number of mutations linked to cardiomyopathy is large, only a small subset of these
mutations have been studied for their effect on myosin mechanics.
Though rare, the MYH11 mutations identified in FTAAD families are deletions
and missense mutations primarily located in the coiled-coil domain of the protein (Pannu
et al. 2007, Zhu et al. 2007). Identification of many of these mutations has proven to be
difficult due to the fact that rare, nonsynonymous variants occur in MYH11 in the general
population (0.6% according to the exome rare variant database, Kuang et al. 2012).
However, a recurrent MYH11 rare variant, R247C, is located in the motor domain of the
myosin heavy chain and disrupts an arginine that is completely conserved across species.
Also, a mutation in the corresponding amino residue in cardiac myosin (MYH7), R249Q,
causes familial hypertrophic cardiomyopathy. The mutation in both the cardiac and
smooth muscle isoforms lies near the ATP binding domain, and in vitro assays of MYH7
R249Q have confirmed decreased ATPase activity and filament velocity (Sata and Ikebe
1996, Roopnarine and Leinwand 1998).
To quantify altered motor function of the R247C MYH11 mutation, Kuang et al.
used a fragment containing the myosin motor domain (HMM) and found a decrease in
actin-activated ATPase activity after phosphorylation of the MLC. In the absence of
MLC phosphorylation, regulation was not altered in the mutant and no ATPase activity
was detected, as is seen in wild type myosin (Kuang et al. 2012). They also measured the
rate of Pi release after the R247C MYH11 was allowed to bind and hydrolyze ATP and
then mixed with actin. As noted earlier, this step is rate-limiting for the overall ATPase
cycle in smooth muscle and initiates the force generating states on actin (Sweeney and
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Houdusse 2010). Pi release was found to be slower for the mutant myosin and was
notably only slightly faster than the overall ATPase cycle rate for both mutant and WT
proteins, consistent with it being the rate-limiting step. Lastly, they measured the release
of ADP, an event that limits both the rate of myosin detachment from actin and maximal
shortening velocity. The rate of ADP release was slower in the R247C mutant, as was
the rate of actin filament sliding in an in vitro motility assay.
To reconcile the kinetic findings on R247C it is important to consider the total
time that myosin spends bound strongly to actin during the ATPase cycle (i.e. duty ratio)
as this will be a major determinant of the total force that myosin produces. In the context
of net force, the rate of Pi release controls exit from the weakly bound (i.e. non-force
generating) states and ADP release controls exit from the strongly bound (i.e. force
generating) states. The calculated duty ratio of the R247C mutant was nearly half that of
the WT protein, and thus force production and shortening velocity are both likely
decreased in vivo due to the mutation. To determine the affect of this mutation in vivo,
mice carrying the R247C mutation were generated and assayed for aortic force
development. These mutant mice were found to have decreased contractile force
compared to controls, and importantly had no change in MLC phosphorylation
suggesting the changes were indeed due to intrinsic properties of the mutated myosin.
This decreased aortic contractility did not cause aortic pathology in these mice,
suggesting that contractility alone may not be sufficient to cause TAAD. SMCs
explanted from the mutant mice also displayed increased proliferation and
dedifferentiation. In contrast to R247C mutants, Myh11 deficient mice die shortly after
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birth due to vascular complications, and from dysfunction of the bladder and intestine
(Morano et al. 2000). R247C mutant mice do not display any deficiencies in visceral
smooth muscle, which could be due to compensation by the nervous system, hormones,
or other type II myosin motors that are sufficient to maintain tissue functionality.
Though the specific role of this mutation in TAAD remains to be seen, R247C
can alter duty ratio and contractile force in vivo and this suggests that missense motor
domain mutations have dramatic affects on smooth muscle contraction. Work has also
been described in MYH7, the cardiac beta-myosin heavy chain, showing that mutations
typically cluster in the functional subdomains of the myosin motor head domain,
specifically in the ATP-binding and actin binding clefts, these mutations are correlated
with human vascular disease but their specific functional consequences are not known
(Buvoli et al. 2008). Aside from R247C, TAAD mutations do not often occur in the head
domain, but rather in the coiled-coil rod domain. One additional exception to this is a
missense mutation at amino acid 712 near the converter domain, which transduces force
from the ATPase motor and allow the flexible movement of the myosin head along actin.
However, as more mutations in both the motor and helix domains are studied we will be
able to better grasp how these missense mutations can alter the in vivo function of smooth
muscle tissues and vascular disease.
In the airway smooth muscle of the lung, contraction must be tightly coordinated
to maintain a constant force output upon the tissue. The mechanical strain that is placed
upon the smooth muscle during lung inflation perturbs the binding of myosin to actin due
to the mechanical force acting upon the actomyosin interaction (Seow and Fredberg
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2001). This response by the major contractile components allows the tissue to be more
amenable to stretch and is required for normal breathing to take place. In situations
where more actomyosin bridges are formed the tissue becomes less compliant as the
muscle stiffens. When in the so-called ‘statically equilibrated’ state, the myosin cycling
and rate of ATP utilization becomes greatly decreased (Fredberg et al. 1999), and an
asthma-associated condition termed airway hyperresponsiveness can occur. This
condition occurs in airways that narrow too readily and too much in response to treatment
with nonspecific contractile agonists, it is also the feature underlying excessive airway
narrowing seen in asthma, but the specific mechanism remains unknown (Woolcock and
Peat 1989, King et al. 1999). In the smooth muscle myosin mutants that we have
identified, unregulated ATPase activity has been observed in two cases where it is highly
likely that additional actomyosin bridges are being formed between unphosphorylated
myosin heads and actin. This could have the similar affect seen in the airway and thus
generate less compliant intestinal tissue. Although the intestine does not experience the
same degree of strain as the lungs do, the tightly coordinated contractile waves are vital
for its function. In addition, we have previously demonstrated that increasing gut
contraction in heterozygous mlt larvae after treatment with L-NAME, a general
contractile agonist, can induce epithelial invasion suggesting that a similar
‘hyperresponsive’ state is achieved in these larvae similar to what has been described in
the airway.
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4.3: Myosin Domains and Contractile Force Output
4.3.1: The Importance of the Myosin Switch I Domain
Within the myosin motor domain, there are multiple subdomains that are linked
through highly conserved ‘connector’ domains. One domain, the converter, has a high
potential for movement due to its connection with two deformable joints, the relay and
SH1 helix. It is this conformation that allows small movements at the motor domain to
be amplified during contraction. A critical connector, known as the Switch I domain,
allows coupling between the actin and nucleotide binding sites. Briefly, during the
‘prepowerstroke’ state partial closure of the large cleft involves the inner part of the cleft,
a domain adjacent to Switch I, trapping the Pi. As has been shown in myosin V, the
nucleotide-free rigor-like state causes the outer and inner cleft to close and generates a
new actin-binding interface that has a strong affinity to myosin (Fisher et al. 1995, Yount
et al. 1995, Coureux et al. 2003). Interestingly, it was reported that the polarity of the
amino acid side chain located at S236 in Myh11 impacted the affect each mutation had
on ATPase function, suggesting that this serine is critical for myosin motor function (Li
et al. 1998, Frye et al. 2010). From what we have found with the S237Y mutant, where
ATPase activity persists when myosin in unphosphorylated, it seems clear that this
domain of myosin has critical functional implications for ATP hydrolysis. At the level of
the intestinal tissue, our in vivo assays reveal that this mutation alters the coordination of
muscle contraction and production of force. With what is known about Switch I’s
structural role within the myosin head, it is apparent that small structural changes in
myosin can lead to significant changes in contraction as we have observed with S237Y.
	
  

	
  

104	
  	
  

	
  

4.3.2: Regulatory implications of myosin tail domain
The assembly of myosin dimers and their proper orientation is directed by an
alternating 28-residue pseudo repeat of the α-helical coiled-coil domain of the tail domain
and this forms the core of the thick filament. The coiled-coil domain of the myosin tail
directs both dimerization and the overall conformation of myosin structure. Smooth
muscle myosin in particular has been shown to be more prone to bent conformations, but
it is still unknown exactly which domains along the helical tail are responsible for the
increased bending (Trybus et al. 1982). The physiological relevance of a more bent
myosin confirmation is also unknown, though it has been long appreciated that changes
in the head domain after phosphorylation of MLC can alter filament assembly at the tail.
Additional studies of the importance of the tail domain used various chimeric constructs
to determine how each domain of the tail altered actin-activated ATPase function in vitro
(Trybus et al. 1997). They tested the role of dimerization in the regulation of ATPase
activity by the myosin head and determined that a tail domain was required, and needed
to be at least the same length as the head domain in order to allow for proper function.
Interestingly, the tail domain was shown to be crucially important for myosin to achieve
its ‘off’ state, a state that is absolutely necessary for normal contractile regulation. The
role of the tail therefore mediates specific interactions with the myosin head, and if these
interactions are obstructed then unphosphorylated crossbridges can slowly continue to
cycle.
These observations could be of critical importance when considering L1287M,
the tail domain mutant that we have described above. In L1287M/mlt trans	
  

	
  

105	
  	
  

	
  

heterozygotes we observe epithelial invasion characteristic of homozygous mlt, and we
have previously shown that the mlt mutation (W512R) results in active cycling of
unphosphorylated crossbridges. Therefore, the unphosphorylated heads are likely of
critical importance in propagating the epithelial phenotype in mlt and in the modifier
trans-heterozygotes. We have already shown that activation of unphosphorylated heads
occurs in the S237Y mutant and this is likely to be the case in L1287M as well. Further,
the L1287M mutant presents us the unique opportunity to better understand how a
myosin tail domain mutation can regulate both ATPase activity and smooth muscle
contraction in vivo.
4.3.3: Trans-heterozygotes: A Potential Interaction Between Mutated Myosin Heads?
At the level of individual myosin heads, each can maximize their duty ratio when
actin concentration is high. The higher duty ratio ensures that when one head detaches
from actin upon ATP rebinding, the second head in the dimer will be in a strong binding
state and remain in this state until the detached head hydrolyzes ATP and rebinds at a
distal actin-binding site. In this manner, certain myosins can processively walk along an
actin filament in hand-overhand fashion through the cycling of only a single head (Yildiz
et al. 2003, Yildiz et al. 2004), a phenomenon that has been seen in vitro and in living
cells (Nelson et al. 2009, Pierobon et al. 2009). A well-studied example of this is myosin
V, where a high duty ratio is required to support its processive movements and actinactivated Pi release (De La Cruz et al. 1999). Myosin V simultaneously decreases the
rate of ADP release such that the strongly attached myosin head becomes the
predominant steady-state intermediate of the cycle. The coordinated regulation of ATP
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hydrolysis at individual myosin heads can be attributed in part to regulatory mechanisms
leading to MLC phosphorylation but the role of the regulatory domains of each myosin
protein has been shown to be of critical importance as well.
The double-headed structure of myosin is not necessary for actin binding or ATP
hydrolysis, in fact a single-headed molecule can alone move actin filament, albeit less
effectively than a two-headed myosin (Margossian and Lowey 1973, Toyoshima et al.
1987, Waller et al. 1995). More recently, it was determined that the step size was twice
as large in a two headed myosin when compared to single-headed molecules (Tyska et al.
1999) suggesting that two heads are more effective than one and that they may work
together to coordinate contraction. Additionally, the strain produced at the junction
between the two heads has been shown to influence actin binding ability, an effect more
striking in smooth muscle myosin (Whittaker et al. 1995, Conibear and Geeves 1998,
Conibear 1999). Taken together, these observations highlight the complexity of doubleheaded molecules rather than simply being two kinetically independent heads. In work
by Rovner et al., the performance of homo- and heterodimeric double-headed myosins
was tested to shed light on the complex nature of their interactions. This study
determined that heterodimers with one mutant head only bind actin weakly, but were
more efficient than single heads or mutant homodimers. This suggests that the weak
binding of the mutant head optimally orients the working head so that it can achieve
maximal performance. A second interpretation is that the second head simply maintains
the structure of the dimer allowing more efficient movement by the working head, which
suggests that actin binding would not be required (Kad et al. 2003, Rovner et al. 2003).
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If we extend these findings to our observations in S237Y or L1287M/mlt transheterozygotes, it suggests that the modifier mutant head binds weakly to actin allowing
the mlt head to produce maximal force and drive the phenotype. Consistent with this is
the observation that heterozygous mlt do not develop a phenotype, likely due to the wild
type myosin head providing the primary mode of contraction while the mlt head serves a
structural role. Additionally, this would explain why we do not observe epithelial
invasion in S237Y and L1287M homozygotes, as these mutant homodimers can only
bind weakly and are not able to reach the contractile force threshold required for
epithelial invasion. It is not clear precisely what ratio of homo- and heterodimers exist in
each heterozygous state discussed above, but the overall number and specific types of
dimers in each context are likely indicators of the contractile force output. Therefore, in
addition to the specific myosin mutation with respect its location within the protein,
altered dimer function is an important consideration when determining the net effect on
muscle contraction.
4.4: Triggering and Responding to Mechanotransduction
In a number of different tissues, the role of force signaling has been shown to
cause diverse responses by the neighboring cells. For instance, in kidney epithelial cells
respond to levels of fluid shear similar to those produced by urine flow in collecting ducts
by increasing calcium influx. Also, changes in gene expression and growth of bladder
smooth muscle cells that are triggered by outlet obstruction appear to result from
mechanical stretch secondary to overfilling of the bladder (Park et al. 1999). During
pregnancy, the onset of labor is triggered by distension of the uterus imposed by the
	
  

	
  

108	
  	
  

	
  

growing fetus, and pulmonary epithelial cells increase secretion of surfactant when
stretched in vitro, just as they do in a newborn taking its first breath (Wirtz and Dobbs
1990, Oldenhof et al. 2002). Pulmonary hypertension, urinary frequency, and irritable
bowel syndrome have each been associated with muscle cell hypercontractility, though
additional factors likely play a role as well. Recent studies suggest that genetic mutations
or malfunction of cytoskeletal proteins, ECM molecules or integrins that alter cell and
tissue mechanics can lead to impaired vascular smooth muscle and cardiac muscle
contractility (Balogh et al. 2002, Loufrani et al. 2002). In contrast, decreased smooth
muscle cell contractility results in urinary stress incontinence, as well as defects in male
and female sexual function (Italiano et al. 1998, Levin 2002). Abnormal muscle tone
also can lead to destabilization of the skeleton and contribute to skeletal and joint
diseases. For example, axial muscular dysfunction has been implicated in the
development of joint pathology in ankylosing spondylitis (Masi and Walsh 2003).
Abnormal fibrillin deposition in patients with Marfan’s syndrome alters the vascular
endothelial cell response to hemodynamic stresses and results in aortic dissection due to
local weakness of the vascular wall (Westaby 1999). Changes in ECM structure that alter
tissue mechanics and provide a constitutive stimulus for cell growth may even contribute
to cancer initiation and progression (Ingber et al. 1981, Sternlicht et al. 2000, Ingber
2002). For example, overexpression of an ECM-degrading enzyme in transgenic mice
results in formation of malignant tumors (Sternlicht et al. 1999). Though each of these
examples is quite different, they emphasize the widespread effect that altered mechanical
signaling can have and additional examples of this are still being characterized.
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Tensional forces are resisted and balanced by external adhesions to ECM and
neighboring cells, and by other molecular filaments that locally resist inward-directed
tensional forces inside the cytoskeleton. This type of force balance is a hallmark of an
architectural system known as ‘tensegrity’ (Ingber 2003) and the viscoelastic behavior of
living cells results from collective mechanical interactions within the tensed molecular
cytoskeleton. Cytoskeletal forces are harnessed in muscle to generate tensional forces
that are important for cell contractility and movement. The effects of applied stresses on
cell shape and mechanics depend on the material properties of the cytoskeletal filaments
and the level of isometric tension in the cell. This occurs similarly to the mechanical
responsiveness of whole muscle, which is governed by its structural organization and by
its contractile tone.
Recognition of the importance of mechanics and cellular mechanotransduction for
tissue development also may help to explain the focal incidence of disease. Although
high cholesterol and LDL promote atherosclerotic plaque formation, these plaques
preferentially form in regions of disturbed blood flow (e.g. near vessel branches) (Davies
1995). Local changes in tissue structure also may explain why genetic diseases,
including cancer, often present focally. Mechanical therapies have been used to alter
tension using engineered devices that act through alterations in microscale forces (e.g.
cell stretching) that activate cellular signal transduction (Langevin et al. 2001, Webb
2002). The therapeutic value of physical therapy, massage, and muscle stimulation is
also well known, and even acupuncture therapy appears to result from ECM distortion as
associated integrin-dependent changes in mechanotransduction (Langevin et al. 2001). In
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our observations of the phenotype in mlt we have observed focal regions of invasion
occurring, suggesting that forces are also applied locally but currently our assays do not
have the resolution to detect these changes.
In smooth muscle cells, mechanical stresses can alter receptor or protein
conformation (Shaw and Xu 2003) and also potentially influence the mechanical output
of the cells. A number of studies have observed differences in the biomechanical
properties of smooth muscle cells in the vasculature (VanDijk et al. 1984), bladder (Yu et
al. 2003) and the airway (Smith et al. 2005). Within the GI tract, it has been indicated
that smooth muscle strips that lacked enteric nerves could contract in response to stretch,
suggesting that mechanosensitivity can occur intrinsically at the level of the smooth
muscle cell (Farrugia et al. 1999). In addition to the direct implication of GI smooth
muscle contractility, a study by Risse et al. found altered smooth muscle contraction in a
mouse model for cystic fibrosis. In this report, it was shown that dissected intestinal
muscle strips exhibited higher contractility in mutant mice with cystic fibrosis than in
wild type controls (Risse et al. 2012). Mechanical measurements of isolated GI smooth
muscle cells were consistent with measurements in other smooth muscle tissues, which
overall are notably softer than other cell types (i.e. blood, endothelial cells, and
chondrocytes) (Liao et al. 2006). In addition, smooth muscle cells in the GI tract are
constantly being deformed due to forces generated by the muscle cells themselves or by
the surroundings (Tanaka et al. 2000, Gregersen et al. 2002). Therefore, the intestine
represents an environment where local contractile force alterations could certainly reside
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and result in focally applied mechanical signals, as we believe is the case in early mlt
mutants.
4.4.1: Tissue Stiffness and Cancer Invasion
Aside from the genetic and biochemical events that proceed during tumor
development, recent findings lend support to the role of biomechanical factors in tissue
development and maintenance (Paszek and Weaver 2004). During early tumor expansion,
the surrounding tissue becomes compressed and interstitial pressure increases, altering
the tissue tension within the stroma. Additional stiffening also happens at the cell contact
level, where actomyosin contractions and Rho GTPase activity compromise cell junctions
and alter cell polarity, while ECM stiffening drives focal adhesion formation. Forceinduced effects can also widely vary based up the direction the force is being applied and
its duration. One example of this is TGF- β1 signaling in smooth muscle cells, where
transient forces increase its expression but if a constant force is applied both TGF-β1 and
collagen I become upregulated (Gutierrez and Perr 1999). This has also been observed in
fibroblasts where dynamic forces increase MMP-9 but static force upregulates MMP-2
(Prajapati et al. 2000). An outstanding question remains as to how each applied force can
induce different cellular responses that can often occur in the complex environment
surrounding a tumor.
Extracellular matrix (ECM) orientation mediates tension-dependent cell migration
to orchestrate developmental processes such as gastrulation (Keller et al. 2003), and
matrix rigidity influences cell growth, differentiation, and motility (Lo et al. 2000, Engler
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et al. 2004, Yeung et al. 2005). Matrix compliance influences Rho activity and ERKdependent growth (Wang and Bitar 1998, Wozniak et al. 2003), and cytoskeleton tension
promotes growth (Roovers and Assoian 2003) and focal adhesion (FA) assembly
(Burridge and Wennerberg 2004). It has also been postulated that tissue stiffness could
drive transformation by increasing Rho-generated cytoskeletal tension via integrin
signaling. Integrins are transmembrane ECM receptors that can function as
mechanotransducers (Bershadsky et al. 2003), integrins regulate Rho- and ERKdependent growth (Lee and Juliano 2004). Integrin expression is higher in epithelia on
rigid substrates than complaint surfaces (Delcommenne and Streuli 1995), and matrix
rigidity increases integrin expression (Yeung et al. 2005). Thus, tissue stiffness could
drive expression of a malignant phenotype through force-dependent regulation of integrin
activity. Indeed, integrin levels and signaling are altered in ‘stiff’ tumors (Guo and
Giancotti 2004).
Paszek et al. found that even small increases in matrix rigidity will perturb tissue
architecture and enhance growth by inducing Rho-generated cytoskeletal tension to
promote FA assembly and increase ERK activation. Their data suggests a
mechanoregulatory circuit that functions to integrate physical cues from the ECM (i.e.
exogenous force) with FA assembly through ERK- and Rho-dependent cytoskeletal
contractility to regulate cell and tissue phenotype (Paszek et al. 2005). Thus, tensional
homeostasis may be essential for normal tissue growth and differentiation, and increasing
tissue rigidity by stiffening the matrix (fibrosis) or by elevating Rho signaling through,
for example, oncogene (Ras)-driven ERK activation, could induce cytoskeletal
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contractility to enhance integrin-dependent growth and destabilize tissue architecture
(Zhong et al. 1997).
4.4.2: ECM Signaling in Response to Stiffness: A Clue From Tissue Development?
Cell growth, differentiation, and motility can all be influenced by physical
distortion of cells through their ECM adhesions. Mammary and retinal epithelium can be
switched from growth to differentiation by decreasing the stiffness or adhesivity of the
ECM, and thereby promoting cell retraction and rounding (Opas 1989). Varying the
mechanical compliance (flexibility) of the ECM also influences the rate of cell migration
and the direction of motility can be affected by geometric cues from the ECM (Lo et al.
2000, Parker et al. 2002). Changing vascular smooth muscle cell shape through
modulation of cell-ECM adhesion or alteration of ECM compliance also regulates its
contractile response to vasoagonists (Lee et al. 1998).
Cell shape-dependent changes in the sensitivity of the contractile machinery may
ensure ‘compliance matching’ in muscle cells of the gastrointestinal tract, blood vessels,
as well as in epithelial and connective tissues, so that the level of tension exerted by the
cell precisely balances the mechanical stress transmitted through the surrounding ECM in
response to tissue distortion. During tissue development, local alterations in ECM
structure that influence cell shape and mechanics, such as thinning of basement
membrane produced by increased ECM turnover (e.g. metalloproteinase activities), also
appear to drive regional changes in cell growth and motility. Skin epithelium, bone cells,
and embryonic heart muscle cells all increase their growth rates when they experience
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mechanical strain (Miller et al. 2000, Hatton et al. 2003). Endothelium sense fluid shear
stress and respond by altering expression of proteins involved in handling oxidative stress.
Mechanical forces have also been shown to be important in the developing vasculature
where pressure and shear stress from pumping blood affects the morphology of the heart
and vasculature. Bones are also shaped by forces produced by muscle contraction during
development and lungs rely on airway contractions to regulate their physiology.
Mechanotransduction during early development has been proposed from
observing the effects of stretching embryos in vitro and altering mechanical forces in
vivo (Beloussov et al. 1988, Beloussov 1990). Morphogenetic movements during
development can be regulated by physical force as well as the coordinated growth of
individual tissues (Orr et al. 2006). In Drosophila, there is evidence suggesting
mechanical activation of the transcription factor Twist (Farge 2003). In this system,
Twist expression in the anterior foregut and stomodeal primordial appears to be initiated
by a force applied onto these tissues by germ band extension. The authors also applied
force experimentally and were able to ectopically express Twist. Mechanical tension in
Drosophila has also been proposed to regulate transcription in migrating border cells
(Somogyi and Rorth 2004). They observed that MAL-D, an SRF cofactor, requires the
force from stretch in order to translocate from the cytoplasm to the nucleus and they
could block this translocation by preventing cellular elongation.
With the large number of diverse processes being controlled by mechanical
signaling or abnormal muscle contraction, there is clearly a number of emerging
questions as to how tissues are responding to these stimuli. These questions can be
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addressed, in part, by assessing myosins role in force propagation as well as its ability to
cooperate with neighboring heads or modulatory proteins such as h-CaD. Understanding
smooth muscle contraction in vivo as well as its effect on underlying epithelial cells will
begin to shed light on biological processes that transmit mechanical signals between
neighboring tissues. However, it remains to be determined how widespread mechanical
signaling is in disease states and during development. If the underlying mechanistic
properties are similar in each context then understanding the modulation of smooth
muscle contraction could provide insight into the nature of force propagation in muscle
and between cells.
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Appendix: Materials and Methods
Morpholino Knockdown
All morpholinos were injected into 1- to 4-cell stage fertilized embryos. Injection
of 620 pg of a morpholino directed against the 5’ region of the zebrafish smooth muscle
myosin heavy chain cDNA that overlapped the predicted translation initiation site
rescued mlt mutants (5’-ATCATCGCTCAAGCCTTTCTTCGTC-3’). Injection of lower
doses generated partially rescued mlt mutants that were discarded from further analyses.
Fully rescued mutants were identified using Kompetitive Allele Specific PCR (KASP).
For smooth muscle Caldesmon knockdown, fertilized embryos were injected at
one cell stage with 20 pg of cald1 morpholino. Zebrafish embryos were microinjected
with a morpholino targeting the splice acceptor site of exon 5 of zebrafish cald1 (5’TTATTCCCCTACAAACAGAACTGCA-3’; Gene-Tools, Corvallis, OR, USA).
Morpholinos were injected as described. The sequence of the control morpholino is
TGCGCGCCAGACAGGGTGATGAC. The h-CaD morpholino was designed against the
smooth-muscle-specific exon of Caldesmon (based on acc. # BC158175), which was
identified from intestinal smooth muscle cDNA. Injection of ~20 pg caused an in-frame
deletion of this exon but had no effect on transcript of the low molecular weight isoform
(Abrams et al. 2012).
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RT-PCR
Intestines manually dissected from 5 day post-fertilization embryos were
homogenized in Trizol (Sigma Aldrich, St. Louis, MO, USA) and total RNA was
collected following the manufacturer's protocol. First strand cDNA was synthesized
using the SuperScript™ III Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s procedure.

When necessary for sequencing, amplified

cDNA fragments were cloned into the pGEM®-T Easy Vector (Promega, Madison, WI
USA). Primer sequences are listed in table below.

Generation of CALD1 Myosin- and Actin-binding Peptide Transgenic Fish
Primers corresponding to the human CALD1 myosin binding peptide (Lee et al.
2000) were identified in the zebrafish cald1cDNA. Transgenic constructs were generated
with the peptide fragment by Tol2kit site-specific recombination-based cloning. A 162
bp fragment was amplified from zebrafish intestinal cDNA and cloned in frame into an
expression construct encoding a cDNA for the viral 2A recognition peptide (Provost et al.
2007) upstream of the green fluorescent protein cDNA. The expression construct also
included a previously reported promoter fragment from the zebrafish sm22a gene (Seiler
et al. 2010) and Tol2 inverted repeats at each end. 20ng µL-1 of DNA encoding the
expression construct was injected into newly fertilized embryos along with 20ng µL-1 in
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vitro transcribed mRNA for the Tol2 transposase as previously reported. All fragments
were cloned using the multisite gateway system (Kwan et al. 2007, Villefranc et al. 2007).
Peristalsis Assay
Wild type, transgenic, morpholino injected, and mutant larvae were fed paramecia
in media containing fluorescent latex beads (FluoresbriteTM YG2.0; Polysciences,
Warrington, PA, USA; 5 µL beads per 2 mL of embryo media) for 2 hours - 6 hours.
Larvae were then screened for fluorescence in the anterior intestine, placed in media
containing only paramecia, and monitored for bead expulsion using a fluorescent
dissecting microscope (Olympus, MVX-10). For time-lapse movies of intestinal
contraction, larvae were anesthetized with equal amounts of tricaine (64 mg L-1) and
mounted in 3% methylcellulose. Images were obtained at 5 second – 15 second intervals
for 2 minutes – 6 minutes using an RGB Vision digital camera (Roper Scientific
Photometrics, Tucson, AZ, USA) and Image-Pro Plus Version 6.0 software (Media
Cybernetics, Bethesda, MD, USA).
Cell Dissociation and FACS
Intestines dissected from 3dpf Tg(sm22a:GFP; miR194:mCherry) larvae were
collected in DMEM (Gibco) and dissociated in 0.25% trypsin EDTA by pipetting. Cells
were collected by centrifugation for 10 minutes at 620 g at 4°C and resuspended in
5%FCS/DMEM. Cells were labeled with 0.2µg mL-1 DAPI to determine cell survival
and sorted using FACSVantage™ SE with FACSDiva™ Software (BD Biosciences, San
Jose, CA, USA). Sorted cells were promptly collected by centrifugation and frozen in
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liquid N2. Total RNA was purified using RNAqueous®-Micro Kit (Applied
Biosystems/Ambion, Austin, TX, USA) and used as a template for cDNA synthesis.
Western Blot/ Immunoprecipitation
Dissected intestines from 30 larvae at 4 dpf and 6 dpf were homogenized in 1x
sample buffer, protein was recovered and used for Western analysis using standard
methods (Davuluri et al.). Western blots were probed with anti-human beta-actin
(Sigma-Aldrich); anti-mouse Caldesmon (a generous gift of Albert Wang); and antirabbit phospho-Caldesmon (serine 789; Upstate Biotechnology) using standard
procedures.
For immunoprecipitation, intestines dissected from morpholino injected and
uninjected Tg(sm22a:CaDDK51-GFP) larvae were fixed in 1% formaldehyde for 15 min
at room temperature. Proteins were isolated by adding cell lysis buffer (50mM Tris-Cl,
10mM EDTA, 1%SDS and protease inhibitors), incubated on ice for 10 min and then
centrifuged at 14000rpm for 10 min at 4°C. Supernatant was removed and the pellet
diluted to 200ml in IP dilution buffer (0.01% SDS, 1.1% Triton X100, 1.2mM EDTA,
16.7mM Tris-Cl, 167mM NaCl). 1ug of rabbit anti-Caldesmon (Albert Wang) or smooth
myosin antibody (Sigma Aldrich) was added and the mixture incubated overnight at 4°C.
10ml of Protein A/G Agarose (Santa Cruz Biotechnology) was added to the samples and
incubated for 2hr at 4°C. The samples were then washed 3 times with PBST and the
pellet was dissolved in 50ml of sample buffer. 25ul of samples were run on a 10% SDSPAGE gel for western analysis.
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Zebrafish Husbandry and Mutagenesis
Maintenance and breeding were performed as previously described (Wallace et al.
2005). colourless mutants were purchased from the Zebrafish International Resource
Center (Eugene, OR, USA). Larvae were raised at 28°C in E3 medium and were staged
by age and morphological criteria (size of yolk extension and pigment pattern around
yolk extension). Expression of mCherry, Lifeact-GFP (Riedl et al. 2008), and GFPKRASG12V (a generous gift from Steven Leach) in the intestinal epithelium was driven by
a 2 kb promoter fragment from the zebrafish miR194 gene (Seiler et al. 2012). Expression
of GFP in smooth muscle was driven by a promoter fragment from the zebrafish sm22alpha gene (Seiler et al. 2010). Zebrafish axin1 mutants were obtained from the
Zebrafish International Resource Center. Mutagenesis was performed on males of Tu
and AB strains according to the scheme outlined by Dosch et al. (Dosch et al. 2004).
Immunostaining
3 dpf old larvae were anesthetized with 0.1 mg/ml Tricaine, fixed in 4% PFA/PBS,
washed in PBST (PBS+0.1% Tween), dehydrated in methanol, and stored at −20°C. For
whole mount staining with anti-laminin and anti-cytokeratin antibodies, larvae were
washed in PBST and permeabilized by a 15-min Proteinase K digestion (100 ug/ml in
PBST). They were then rinsed in PBST and postfixed in 4% PFA/PBST. The skin above
the trunk and intestine was removed using fine forceps. Larvae were stained with
antibody in 10% goat serum/PBST. The laminin antibody (Sigma #L-9393) was used at
1:50 or 1:200 dilution; the cytokeratin antibody (Thermo Scientific clone AE1/AE3, MS	
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343-PO) was used at 1:100 dilution. Secondary antibodies were labeled with Alexa 568
or 488 (Molecular Probes/Invitrogen). Histological analyses of the mounted specimens
were performed as described (Wallace et al. 2005).
Drug Treatments
Larvae were bathed in 1.5 µM Menadione (MP biomedicals) in E3 media for 3 h
(3 dpf larvae) or 5 h (5 dpf larvae).
Construction of Human Smooth Muscle Myosin II (MYH11)
The cDNA for human MYH11 (SM1A isoform) was truncated at the codon for
threonine 1775 (creates a soluble ‘HMM’ construct), after which a glycine plus FLAG
peptide (DYKDDDDK) was appended to facilitate purification. Site-directed
mutagenesis was performed using Quickchange XLII kit (Stratagene) to introduce the
S237Y mutation into the same construct. The constructs were subcloned into the
baculovirus transfer vector, p2Bac (Invitrogen). Protein expression and purification were
as previously described (Sweeney et al. 1998). The HMM construct had been previously
subcloned into the baculovirus transfer vector, pVL 1393 (Invitrogen). Baculovirus
expression was used to produce HMM fragments of smooth muscle myosin after
infection of an insect cell line (Sf9) with recombinant baculovirus (described in detail in
Sweeney at al. 1998 (Sweeney et al. 1998)).
Myosin ATPase Assay and Transient Kinetic Assays
As described previously in Kuang et al. 2012 (Kuang et al. 2012), the actin	
  

	
  

122	
  	
  

	
  

activated ATPase activity assay was performed at 25°C in buffer 20/20 (KCl 20 mM,
Mg2+ 5 mM, EGTA 1 mM, MOPS 20 mM pH 7.0), ATP 1 mM final concentration and
actin concentration ranging from 0 to 150 µM. Actin was purified from rabbit skeletal
muscle and stabilized by phalloidin. Phosphorylation of HMM WT and mutant constructs
was performed as previously described 10. Both unphosphorylated and phosphorylated
forms of WT and mutant human smooth myosin 2 HMM constructs were assayed at 0.2
nM final concentration. Curves were fitted with Kaleidagraph software TM. Triplicate
assays were performed with three different preparations of each protein. Transient kinetic
measurements (Pi release from myosin and ADP release from actomyosin) were made in
buffer 20/20 at 25°C with an Applied Photophysics SX.18MV stopped-flow instrument
following previously published protocols (De La Cruz et al. 1999). Assays were
performed with three different preparations of each protein.
Tissue Tension Measurements
The elastic moduli (Young's modulus) of intestines isolated from wild type and
mlt larvae were measured using a microprobe indenter device (Levental et al. 2010). This
assay measures the upward force generated by the intestine in response to indentation of
the probe applied to the outer (serosal) surface. Tissue compliance (Young's modulus) is
the slope of the force versus probe indentation curve. Briefly, a tensiometer probe
(Kibron, Inc., Helsinki) with a 100 µm radius flat-bottom needle was mounted on a 3-D
micromanipulator with 160 nm step size (Eppendorf, Inc.) attached to an inverted
microscope. The tissue was adhered to the bottom of a plastic dish filled with DMEM and
imaged by bright field illumination. The bottom of the probe was brought through the air	
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water interface until it rested at the surface of the cylindrical tissue with a diameter of
approximately 80 microns. The probe was calibrated using the known surface tension of a
pure water/air interface, and the stress applied by the tissue to the probe as it was lowered
was measured as a function of indentation depth. In principle, this deformation geometry
is that of an infinite plane compressing a cylindrical object, and the absolute values of
elastic modulus can be calculated from appropriate models that require assumptions
about the adherence of the tissue to the probe and the glass slide, whether the sample is
modeled as a uniform cylinder or an elastic shell, and other structural factors that
confound calculation of the absolute value of elastic modulus from the force-indentation
data.
In this study the primary interest is in the relative stiffness of wild type and
mutant tissue, and therefore we present only the primary data, which consists of the
elastic resistance of the tissues as a function of indentation depth. Indentations (≥13 per
intestine) spanned the range from 160 nm, which would measure small strain reflecting
linear elasticity to indentations, up to 20 microns, which would reveal differences in large
strain deformation or rupture. After the largest indentations, measurements were repeated
at small strains to confirm that the deformations were recoverable. For statistical analyses,
a one-tailed Student's t test for data sets with unequal variance was performed to
determine the significance of differences between Young's moduli of wild type and mlt
intestines samples.
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Vascular Recordings
5 dpf larval zebrafish were anesthetized with equal amounts of tricaine (64 mg L-1)
and mounted in 3% methyl cellulose. All larval vascular flow was recorded for 5 seconds
using a high-speed camera (Motionpro 2000; Redlake, Tuscon, AZ) at 250 fps with a 640
x 480 resolution. Heart rate imaging was recorded for 5 seconds at 125 fps with a 512 x
512 resolution. Quantification of blood flow rate was performed by tracking individual
cells (5/larvae) over a fixed distance within both the artery and vein.
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